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Synthetic genetic circuits are gene regulatory networks used to engineer biological systems
to carry out useful functions. Moving circuits between environments or host cells alters their
function in ways we can’t predict, leading to circuit failures that can only be fixed by laboriously
rebuilding them. Here, we propose a novel regulatory motif that controls transcription and
translation of a gene. We implemented the motif to design a device - a tuneable expression
system (TES) that used a riboregulator to activate translation of a gene in response to cognate
small RNAs (sRNA). Transcription of the gene and sRNA were independently regulated by two
sensors that were activated in response to different inducers, allowing us to dynamically tune
the device’s response function. The TES’s outputs at high and low inputs could be shifted 4.5
and 28-fold, respectively. We tested the TES in a range of glucose concentrations to emulate how
these conditions would affect device performance in industry and found that it produced protein
>2-times faster in higher glucose concentrations. We showed that the TES can be regulated so
protein production rate remains constant in different glucose concentrations. We then used the
TES to build a tuneable repressor protein based NOT gate, whose transition between on and
off states can be tuned over a >6-fold range. However, in all devices, tuning the device reduced
its fold-change and separation between populations of cells with high and low inputs. Using
deterministic and thermodynamic models we found we could improve the device’s performance
by increasing the rate of sRNA transcription and removing a self-cleaving ribozyme insulator
that interfered with riboregulator function. Circuits built using the TES could be tuned and fixed
dynamically, removing the need to reassemble them from new parts and accelerating genetic
circuit development. Furthermore, TESs provide the basis for novel adaptive circuits, systems
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Synthetic biologists re-write the code of life, DNA, to engineer living systems with their own
desired behaviour. Examples include engineered microbes that can: produce sustainable palm
oil [15], convert agricultural waste into building materials [12] and brew beer that doesn’t need
hops adding to it [117]. This has been made possible by advances over the past 50 years that
have identified the function of many genes and regulatory sequences encoded in DNA. Synthetic
biologists exploit this knowledge to build new living systems, preferably in a systematic and
rational way.
1.1 Engineering principles applied to biology
To more predictably modify life, synthetic biologists often apply principles developed by engineers
to simplify the complex processes that occur in living systems. This is achieved by focusing
on the key features for the engineering task at hand. These simplified representations of core
biological processes are combined at different scales to build systems of increasing complexity
(Figure 1.1). At the smallest scale, DNA sequences are thought of as interchangeable parts that
carry out specific functions. These DNA parts are combined to build devices that carry out more
complex functions. Parts and devices can then be combined to build larger genetic circuits. Like
electronic circuits, these sequences of DNA detect an input, perform computations to process this
information, then actuate a desired response. To engineer DNA sequences in this way synthetic
biologists employ four core engineering principles:
1. Abstraction – engineers use simplified representations to describe processes in biological
systems in terms of the functions they perform that are of interest. It’s used across all
different scales of system in biology. We describe a sequence of DNA that carries out
a specific function as a part (Figure 1.1), for example, transcriptional promoters are
sequences of DNA that define where an enzyme, RNA polymerase (RNAP), starts to
1
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Multi-cellular Level 
Population behaviour  
Figure 1.1: Synthetic biology hierarchy A schematic diagram demonstrates the hierarchy of abstrac-
tions used in synthetic biology. As an example, we use a genetic circuit that manipulates the metabolism
of a host cell [96]. Systems increase in complexity from the smaller scale systems (bottom) to larger scale
systems (top). Coloured regions demonstrate abstraction. In yellow, DNA molecules are represented as
sequences of letters. In orange, the function of a genetic part is determined by RNA folding. In green,
transcription of a gene is prevented by a protein that binds to DNA, preventing it being transcribed by
RNA polymerase (RNAP). In purple, the genetic circuit produces less acetate when glucose and oxygen
(O2) are present.
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transcribe a gene. When using a promoter, synthetic biologists are not normally concerned
with the bases that make it’s sequence, they just place the abstracted part upstream of a
gene of interest.
2. Composability – engineers intentionally build components that can be used interchange-
ably, so their functions are maintained in any context. Composability makes it simpler to
build large systems from smaller, modular components (modules). Modules carry out the
same function when they are used on their own or in a system, allowing us to predict how a
large system composed of modules will behave based on how the modules behave on their
own. This makes it simpler to build complex living systems.
3. Decoupling – components are designed so that their activity does not alter the behaviour of
other components in a system. In biological systems, components are made up of biochemical
molecules that constantly diffuse around a cell. Single molecules that are constituents of
one module can affect several others. For example, if a protein in a module binds not only to
a specific sequence of DNA we desire, but to other similar sequences in different modules, it
will affect the behaviour of the other modules, changing how they behave. This effect leads
to unpredictable changes in the system’s behaviour, so to predictably build larger systems,
modules must be decoupled.
4. Standardization – components are built and tested following a set of rules that allow
components to be easily connected together. Using a standardized signal carrier as the
input and output to modules, the output from one module can be used as the input to
another [19], making them easier to connect. For example, by standardizing all devices
to use transcriptional promoters as device inputs and outputs, RNAP flux can be used
as a common signal carrier across devices [13, 19, 100]. Other signal carriers include the
concentration of the active form of a protein or ribosome flux on an mRNA [90].
1.2 The design, build, test, learn cycle
Successfully engineering complex systems with specified functionalities is difficult to accomplish
on a first attempt so a systems development life cycle approach is used. A product is designed, built
and tested in comparison to the initial specification. If the product doesn’t meet the specification,
further cycles are taken until a functional product is conceived. Engineers learn from failed
designs to improve subsequent designs until one is found that fully meets the specification.
Synthetic biologists have adapted this framework to engineer biological systems and manage the
complexity and large uncertainty associated with the task (Figure 1.2).
To create a genetic part, device or circuit, the first step is to develop a design. In the design
stage, we aim to predict the function of a specific DNA sequence. Knowledge from previous
3
CHAPTER 1. INTRODUCTION
experiments and mathematical modelling is used to predict how components will behave when
combined (Figure 1.2).
The build stage of the cycle is generally the most time consuming and expensive. The specific
sequence of DNA encoding a design needs to be accurately constructed into DNA. For the construct
to be tested it needs to be built into a vector which enables the function encoded in the sequence
to be executed.
Once constructs have been built and sequence verified they need to be tested to see if they
carry out the function they were built for. The way devices are tested depends on their end use. If
a system’s performance does not meet specification it needs debugging. This involves identifying
which parts or devices aren’t performing as expected. We then learn from this and modify the
design on the next iteration of the DBTL cycle.
In the learn step, we analyse the results from testing and generate ideas for improving the
design. The DBTL cycle has been shown to be an effective way of developing and optimizing
engineered genetic systems [20]. However, every extra iteration of the cycle costs time and money.
Therefore, reducing the number of times a construct needs to be redesigned and built is highly
beneficial.
Another challenge is that genetic circuits are tested in controlled lab based environments,
irrespective of the environment that the circuit is intended to be used in. For genetic systems
to be used in a real-world context, they need to have robust functions and be able to adapt
Figure 1.2: The design, build, test, learn cycle. Flow diagram of the design-build-test-learn cycle used
to engineer microbes to produce valuable chemicals (reprinted from Commun. Biol., 1, Carbonell et al.,




to environmental perturbations. However, circuits are often tested in carefully controlled lab
conditions and break when deployed to complex, real-world environments [21, 52, 95].
1.3 Motivation
The time taken to create devices that function precisely as desired is often prohibitively long. A
specific example of this is the creation of new metabolic pathways in industrial biotechnology. In
this context, genetic circuits are used to regulate the rate that key enzymes involved in metabolic
pathways are produced. Correct regulation of these enzymes allows for the efficient production of
valuable chemicals. However, the DBTL cycle used to create such pathways is time consuming
and expensive. It is estimated that it takes 50 to 300 person years and millions of pounds to
develop a viable production strain [80]. For synthetic biology to have the greatest impact on
society, we need ways to rapidly scale developments made in the lab to industrial contexts. We
can do this by reducing the time taken for a DBTL cycle to be carried out and the number of
cycles needed to develop a functioning device or circuit.
The motivation of this project was to develop tools and methodologies that make it faster and
cheaper for synthetic biologists to engineer working genetic circuits. More specifically, we aimed
to build genetic devices whose behaviours can be dynamically modified after their assembly
in a circuit. This innovation would cut the cost and time taken to build genetic systems by
removing the need to reassemble the circuit for each DBTL cycle. If the circuit doesn’t work as
intended, we can simply tune the devices until the circuit is fixed, with no reassembly of the
encoding DNA required. This approach focuses on broadening a circuit’s functionalities encoded
in a single design-space – the subset of DNA sequences that could be used to encode a device
or circuit, to improve its performance. However, changing the environment a genetic system is
tested in also alters its performance. Therefore, a genetic component’s test-space – the set of
environmental conditions that circuits are tested in, is just as important. A second aim was to
test genetic circuits in environments that emulate the conditions they will be exposed to in the
real world, allowing us to uncover otherwise unforeseeable design flaws. Testing genetic circuits
in appropriate test-spaces could reduce the time taken for their use to be scaled from the lab into
real-world applications.
1.4 Thesis overview
After presenting some background in Chapter 2, in Chapter 3 we describe the materials and
methods used to undertake this research. In Chapter 4 we present the idea of a device capable of
tuning the rate that a gene is expressed by providing us with a way to independently regulate
rates of transcription and translation. We call this device a tuneable expression system (TES)
and use mathematical modelling to refine its design. We go on to validate the design by building
a plasmid implementation and testing this in-vivo. From experimental data, we show that the
5
CHAPTER 1. INTRODUCTION
device doesn’t perform well and so identify issues with the initial design that could potentially
hinder its performance.
In Chapter 5, we use a combination of deterministic, stochastic and thermodynamic modelling
to test these hypotheses in-silico and based on these results, design new variants of the device.
We then compare the performance of these optimised devices to the original design.
Finally, in Chapter 6, we use the TES to create a tuneable NOT gate that could be used to im-
plement biological computations. We build and test four variants and compare their performance
in-vivo. We then test how glucose concentration affects the performance of the TES.
Excluding Sections 4.5 and 6.4, the contents of this thesis are published in: Vittorio Bartoli,
Grace A. Meaker, Mario di Bernardo and Thomas E. Gorochowski, "Tunable genetic devices





Humans first used biology as technology more than 23,000 years ago, when they first cultivated
plants for sustenance [123]. This innovation was the driving force behind the transition of societies
from being nomadic to being settled, it drastically changed how humans live and literally changed
the face of the Earth [107]. New crops were engineered through the slow process of selection.
Thousands of years after the advent of agriculture came another revolution in biotechnology. The
first evidence of fermentation arose at the same time as the first signs of civilization around 7000
years ago [91]. Fermenting sugars to produce alcohol allowed our ancestors to preserve food and
provided a valuable product that was used as payment for services, allowing leaders to leverage
people power and pursue more ambitious urban projects, leading to the birth of civilization itself
[91].
2.1 The development of biotechnology
The next big step in shaping biotechnology as we know it came in the late 1500s when micro-
scopes were invented [131]. Robert Hooke and Antoni van Leeuwenhoek used microscopes to see
microorganisms (microbes) for the first time. 150 years later, microscopy helped us understand
how microbes play an important role in causing diseases and transforming chemicals [47]. The
next major innovations in biotechnology came thanks again to alcohol. Whilst researching the
production of wine and beer in 1857, Luis Pasteur found that fermentation was caused by mi-
crobes and not the spontaneous decomposition of chemicals, as was previously believed [131].
These discoveries led to the foundation of modern day biotechnology.
The next big wave of innovation in biotechnology came with the discovery of DNA in the 1950s.
DNA was shown to contain information that cells used to produce proteins. In 1978, Warner
Arber, Hamilton Smith and Daniel Nathans won the Nobel prize for their work on endonucleases,
bacterial enzymes that cut the DNA of invading viruses [131]. The discovery of endonucleases,
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along with other innovations at this time, enabled scientists to “edit” DNA. They could “cut” out
and build new fragments of DNA designed to carry out novel functions and place them in living
organisms. The first industrial use of this technology was when scientists engineered Escherichia
coli to produce insulin in the 1970s [131]. This was the first protein produced commercially by a
microbe engineered with this technology.
Biotechnology has always been closely related to economics because funding research and
development is expensive [131]. Funding comes from private or public investors who expect
innovations to directly or indirectly benefit the economy, so it’s crucial that biotechnological
innovations lead to profitable enterprises. The most recent set of innovations in biotechnology
led to the advent of synthetic biology. Cheaper DNA sequencing and synthesis has enabled
scientists to build and test large numbers of genetic designs and to better understand the rules
for reprogramming life. This has led to a more rational approach to engineering biology, which
has the potential to change how we produce many of the chemicals and materials we rely on as a
society.
2.2 Money steers innovation
Microbes can be engineered to convert waste products into valuable chemicals [82]. For example,
waste products from agriculture can be put through industrial processes that use engineered
microbes to convert them into fuels, pharmaceuticals and materials [82, 101]. For these processes
to be commercialized they need to be profitable. A fast way of measuring if a process would
be profitable is to subtract the cost of raw materials (also called feedstock) from the expected
revenues, a figure known as the gross margin [129]. The cost of raw materials is usually 80–90%
of the cost of production, so the gross margin gives an accurate estimation of how profitable a
process will be. A low gross margin suggests that a process is not commercially viable.
To make a process more profitable, two measures of its performance can be improved. First,
the gross margin depends on how much of a raw material can be converted into a product, a value
summarised in the yield, which is the percentage of a raw material converted into a product.
Synthetic biology lets us engineer microbes to produce higher yields of a product. By increasing
the yield, we generate more product from the same amount of feedstock, increasing the gross
margin, making a process more profitable and increasing the chances of it being commercialized.
A second way of increasing the profitability of a process is to increase how much of a product
is produced in a fixed amount of time – the process’s productivity. Productivity is related to the
scale of production; the volume of chemical being used and how rapidly microbes convert these
into a desired product. If we increase scale of production, we can increase how much product
we generate in the same length of time and therefore revenue, however, increasing the scale
of production increases the size or amount of equipment needed to carry out a process. This
increases the initial capital needed. If the microbes used in a process are more productive, the
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same volume of product can be produced in a smaller plant, reducing building costs. Therefore,
engineering productive microbes reduces a process’s capital cost, making investors more likely to
invest.
In the past, productivity, yield and process economics were improved by selectively growing
microbes that produced the best beers, wines, breads and cheeses. Since the 1970s metabolic
engineers have used faster, more effective strategies to engineer microbes for industrial processes.
Valuable chemicals are often found in nature, produced by either plants or microbes [104].
However, these organisms are not always well suited to growth in an industrial plant.
One strategy metabolic engineers use to engineer production strains is to identify genes that
code for sets of enzymes that produce valuable products [101, 104]. They place these genes in
microbial strains that when grown at industrial scales, are able to produce the desired product
at a higher yield and with better productivity than the native strains in which the pathway
was found [80, 101, 104]. Genes that occur naturally in the metabolism of engineered strains
produce enzymes that convert feedstock into worthless waste products. Thus, to further improve
production strains, metabolic engineers turn off the expression of these genes to channel resources
to those genes that produce the desired products [80]. These innovations have improved the
yield and productivity of numerous processes currently being used at a commercial scale [101].
However, engineering strains in this way is time consuming and expensive.
For example, using this approach to develop a viable product requires 50–300 person years
and several million’s of pounds of investment [80]. This is where synthetic biology can help.
New methods to synthesise large DNA fragments open up more rational approaches to engineer
microbes for industry.
2.3 Improving bioproduction with synthetic biology
Cells produce proteins via the multi-step process of gene expression. Information encoded in
DNA is first converted into RNA by RNA polymerase (RNAP) during a step called transcription.
This RNA is then bound by ribosomes that translate it into a sequence of amino acids that fold
to produce a protein. Controlling the rates of transcription and translation is crucial to cellular
functions and synthetic biologists have developed ways of modifying these using biological parts.
By regulating rates in new ways, we can engineer cells to produce proteins when they detect
specific changes in their environments and thus, more effectively produce a product in less time.
A clear example of this approach is by Zhang et al. who improved the production of a biodiesel
– fatty acid ethyl ester (FAEE) [142]. First they engineered a biosensor based on a naturally
occurring promoter, PmodB, that increased the rate of transcription of genes when fatty acids
were present in the cells. They used this sensor to regulate the transcription of four enzymes:
pyruvate decarboxylase (pdc), alcohol dehydrogenase B (adhB), acyltransferase A (atfA) and fatty
acyl-CoA synthetase (fadD). These enzymes work together to produce FAEE from fatty acids. By
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only producing the enzymes when fatty acid was present, energy and nutrients were not wasted
on enzyme synthesis until there was sufficient substrate for them to process. Furthermore, FAEE
is made from ethanol and fatty acyl-CoA. Whilst a necessary intermediate in FAEE production,
ethanol damages cells, which decreases the amount of FAEE that they produce [125]. In this
system, ethanol is produced by enzyme pdc, which is only produced when fatty acid concentration
is high enough to be converted into the intermediate fatty acyl-CoA, which then reacts with
and sequesters ethanol. This reduces the toxic effect of the ethanol when producing FAEE. By
only producing ethanol when it is needed, cells can grow to be healthy and produce FAEE more
effectively, a strategy that resulted in a three–fold increase in yield, from 9% to 28% [142].
This approach can be taken even further. More recently Moser et al. [96] use a synthetic
biology approach to engineer a strain of E. coli that produces less waste by-product during
fermentation. The central metabolism of E. coli produces acetone from glucose [96]. In metabolic
pathways where acetone is not converted into a useful product, less glucose is available to make
the desired product, reducing yield. To overcome this problem, Moser et al. built a genetic circuit
that turns off production of the enzyme that catalyses acetate formation when the concentrations
of glucose and acetate are both high. To do this, they built a genetic circuit to process two input
signals: the concentrations of glucose and acetate. When both acetate and glucose are abundant
in the cell, the circuit turns off transcription of the enzyme that produces acetate. This causes less
glucose to be converted into acetate, leaving more available to be converted into desired products.
Clearly, using genetic devices and circuits to control rates of protein production is valuable for
engineering microbes to produce chemicals more effectively. It differs from traditional metabolic
engineering approaches where whole sets of genes are introduced and merely overproduced in
cells, in a non-optimal and uncontrolled manner.
2.4 Engineering genetic circuits
Genetic parts are interchangeable sequences of DNA that regulate gene expression. Many
parts can be connected together to create devices that perform specific functions. Similarly, by
connecting many devices together their functions can be combined to build more complicated gene
regulatory networks, or genetic circuits. Genetic circuits process information in cells, detecting
an input and generating a required output based on some computation. Circuits are often
hierarchical in structure, requiring many to be connected together to produce more complex
functionalities. To make it easier to connect genetic devices and circuits, it helps if their inputs
and outputs use a standard type of signal. These are often core biological processes. Examples
include: the rate that RNA polymerase is recruited by transcriptional promoters (RNAP flux)
[19], the concentration of a protein and the initiation rate of ribosomes at a ribosome binding
site (RBS) [90]. A genetic device can be characterised by the relationship between its input and
output signals, which a device’s response function captures at steady-state. Response functions
10
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Figure 2.1: Illustration of mismatched genetic NOT gates. (A) Schematic of two NOT gates con-
nected in series. x, is the activity of the input promoter to gate 1. R1 and R2 are repressor proteins that
repress promoter activities y (which is the output from gate 1 and input to gate 2) and y′ (which is the
output from gate 2), respectively. (B) Response functions of gates 1 and 2 were modelled with reverse hill
functions. The response function of gate 2 is fixed, whilst, from top to bottom, the K-value of gate 1 was
simulated at 0.08, 0.001 and 0.005 RPU. High and low inputs to gate 1, x1 and x2, respectively, are the
same in all simulations.
have become central to the rational design of complex circuits in living cells [100].
To connect two devices, their response functions need to be compatible, or matched, i.e. the
range of outputs from the first device must span the necessary range of inputs to the second.
Matching components is crucial when circuits are made from devices that rely on switching
behaviours to carry out computations. For a device to exhibit switching behaviour, its outputs
must switch between two states (significantly different high and low outputs) when its input is
either high or low. If a change in the input signals doesn’t cause the device to switch, the signal
can’t propagate through the circuit, causing it to break. The shape of a response function dictates
whether the difference in input signals is large enough to shift the output signal between on
and off states (Figure 2.1). By modifying the shape of a response function, the functions of two
devices can be made to match. However, if the shape of matched response functions change when
a circuit is being used, it can lead to the circuit failing [13, 130].
A few features of a device’s response function indicate how well it will perform. To gauge
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whether the outputs from a device will be sufficiently different to trigger switching in a down
stream device, the ratio between the devices output in high and low states, also known as its
fold–change is used. A device with a higher fold-change is more likely to trigger switching in
a downstream device. However, caution must be taken in measuring a devices performance by
fold–change alone. If the lowest output from a device is very low, it could result in a device having
a large fold-change, even though the outputs do not span a large range. To account for this, the
difference in a device’s outputs in on and off states are reported. This measure of performance is
the device’s dynamic range.
Changes in environmental conditions such as temperature and the concentration of nutrients
cells are grown in can all alter the behaviour of parts and devices [52, 95]. In some cases
these changes are so great that response functions deviate from their required shape, causing
entire circuits to break. Synthetic biologists claim that genetic circuits can be used in industrial
biotechnology to coordinate gene expression and optimize processes. However, when cells are
grown in industrial bioreactors, conditions such as temperature and concentrations of nutrients
vary significantly over time and location in the reactor. Using cells in these highly variable
environments will change the way that parts designed to be used under static conditions behave.
If we are to create robust genetic systems, it is important that we can tune the function of the
parts it consists of. One way to do this is by controlling the transcriptional and translational
processes used by genetic parts and devices.
2.5 Tuning the rate of transcription
Transcription initiation is a complex process where the core RNAP enzyme interacts with a
sigma factor to form a holoenzyme. The sigma factor portion of the holoenzyme recognizes a
recognition site within a promoter sequence, which the holoenzyme then binds to [14, 56, 134].
The holoenzyme melts the DNA duplex around the transcription start site forming a transcription
bubble; a process that yields a stable open promoter complex that marks the initiation of RNA
synthesis [64]. Once the RNA chain reaches 8–11 nucleotides (nt), the transcription process
transitions to the next step, productive elongation [10, 114]. There are many ways that this
process can be influenced to allow for the rate of transcription to be controlled. The most common
approaches are to use protein or RNA regulators.
2.5.1 Tuning rate of transcription with proteins
Proteins known as transcription factors (TF) are able to control transcription by altering the rate
that RNAP binds promoter sequences. Repressors are TFs that bind an operator sequence. By
placing an operator near or in a promoter the physical presence of the repressors blocks RNAPs
from binding to the DNA, reducing the transcription initiation rate. Ideally, the repressor binds
specifically to its cognate operator site. However, off-target binding can sometimes occur, which
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Figure 2.2: Proteins regulate transcription initiation. (A) Schematic shows how repressors regulate
transcription. (B) Schematic shows how repressor based genetic sensors modify transcription in response
to small molecules. (C) Schematic shows how the CRISPRi system can be used to regulate transcription.
makes engineering regulatory programs a challenge [124]. As the concentration of repressor
protein increases, the rate of transcription initiation decreases, because fewer RNAPs can bind to
the DNA (Figure 2.2A).
Genetic sensors are common in nature [24]. Bacteria use them to sense changes in the
concentration of nutrients in their environment and to regulate the transcription of enzymes
that can digest them in response [69]. A common example is the LacI repressor. LacI binds to
operator sites in the Plac promoter upstream of genes that encode enzymes to metabolise lactose
13
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[37, 49, 119]. LacI is constitutively expressed, preventing these genes being transcribed until a
metabolite of lactose, allolactose, is present. The conversion of lactose into allolactose is catalysed
by the enzyme β-galactosidase, which is encoded in the gene LacZ, one of the genes regulated
by Plac. LacI interacts with allolactose causing a conformational change in the protein that
reduces its affinity for the operator site DNA, allowing RNAP to more readily bind to the Plac
promoter and transcribe the lactose metabolising genes [38]. Thanks to this mechanism, when
allolactose and therefore, lactose is present, bacteria sense it and produce enzymes to metabolise
it. Using this mechanism, the required genes are only expressed when needed, conserving cellular
resources. Lactose is the inducer for the promoter Plac. Synthetic biologists utilize this system
and many other small molecule inducible repressor-promoter pairs to allow them to regulate
the transcription rates of many genes simultaneously (Figure 2.2B) [94, 100, 124, 128, 132].
In the case of Plac, the promoter is placed upstream of the gene to be regulated. Expression of
the gene of interest is controlled by adding lactose or the analogous chemical isopropyl β–d–1–
thiogalactopyranoside (IPTG) to the system [132].
Meyer et al. built on this idea by taking a set of 12 naturally occurring small molecule sensors
and using directed evolution to optimise their performance and reduce their interactions with
each other [92]. The resulting 12 sensors all exhibit fold changes >100 and the low cross-talk
between devices allows them to all be used concurrently in the same cell. They also integrated
the repressor proteins into the genomes of wild type (MG1655), cloning (DH10- β) and protein
expression (BL21) strains of E. coli. This work is significant as it enables the rate of transcription
initiation for up to 12 genes to be regulated simultaneously using small molecules and the
"Marionette" strains, enabling us to build more complicated genetic circuits with many inputs.
To demonstrate the utility of these strains, 5 enzymes in a pathway that produces the valuable
chemical lycopene were put under the regulation of 5 sensors. An optimization strategy was
employed to balance enzyme synthesis in a way that would maximize lycopene production.
972 combinations of inducer were tested, representing 972 different combinations of enzyme
synthesis rates. Their approach yielded a strain that produces 90 mg/L of lycopene, a titer similar
to previous best efforts [139]. If enzyme synthesis rates were balanced using traditional methods,
like varying RBS and promoter strengths, 972 genetic constructs, amounting to 7 Mb of DNA,
would have had to have been built. Using Marionette, optimal enzyme synthesis rates were found
using a single genetic construct, an approach significantly faster and cheaper than building and
testing a library of circuit variants.
A second example of where synthetic biologists have exploited native mechanisms that
regulate genes are two-component systems. These consist of two proteins: a histidine kinase type
enzyme and a response regulator protein (RR) [8]. The activity of the histidine kinase, is activated
in response to external stimuli [77]. The active histidine kinase transfers a phosphoryl group to
the response regulator, which activates it and enables it to either activate or repress a gene by
interacting with a promoter sequence [66]. The way that RRs vary the rate of transcription, varies
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between systems. Two component systems are useful to synthetic biologists because thousands
of them have been identified in nature [62, 77]. They are therefore a large source of possible
genetic sensors for synthetic biologists and their power lies in the fact they can detect a large,
diverse range of stimuli like: antimicrobial peptides [65], human hormones [70] or even specific
wavelengths of light [40].
Landry et al. used synthetic biology to improve a wild type sensor that made it better at
detecting nitrate. They tuned the sensor’s detection threshold, i.e. the concentration of inducer
needed to activate their outputs, by making two different mutations to its histidine kinase –
NarX. The first point mutation (C415R) targets the interface between NarX and its cognate
RR – NarL , which reduces phosphatase activity and therefore the repression of transcription,
increasing the sensor’s sensitivity [66]. The second point mutation (D558V) targets the catalytic
ATP binding domain of NarX , which more strongly reduces phosphatase activity [66]. The C415R
and D558V systems were 34–fold and 381-fold more sensitive, respectively, than the threshold of
the wild type system, which was 762 µM. The C415R more accurately detected nitrate over a
wider range of concentrations in soil treated with commercial fertilizer [77]. It detected nitrate
between concentrations of 5.62 µM and 562 µM, allowing it to detect nitrate concentrations
>5-fold lower than the wild type system, which detected nitrate between 31.6 µM and 562 µM.
A third example of a synthetic transcriptional regulator that has been engineered from a
natural system is the CRISPR interference system (CRISPRi) [108]. CRISPRi allows us to target
and repress transcription of any gene irrespective of the target sequence. The CRISPRi system is
derived from a bacterial genetic immunity pathway, characterised by sequences that feature clus-
tered regularly interspaced short palindromic repeats (CRISPR) [93]. In the modified CRISPRi
system, a single guide RNA (sgRNA) forms a complex with a catalytically inactive (or dead) form
of CRISPR-associated protein 9 (Cas9), a protein that normally catalyses the formation of double
stranded breaks in target DNA. The sgRNA guides the complex to a complementary target site
on a DNA strand that dCas9 binds to (Figure 2.2C). By making the sgRNA complementary to a
promoter of interest, dCas9 can be used to block RNAPs and repress transcription of downstream
genes by up to 100–fold [108].
2.5.2 Tuning rate of transcription with RNA
The process of gene transcription is made up of many sub-steps. After transcription initiation,
during a process called promoter escape, the RNAP holoenzyme, which is bound to the promoter
sequence through its sigma factor, usually releases its sigma factor, removing its contact with the
promoter and allowing the RNAP to "escape" [3, 112]. The enzyme undergoes a conformational
change and the initiation complex between the RNA, DNA and RNAP is converted into a highly
stable elongation complex [97]. In the next step, elongation, the RNAP-nucleic acid complex cycles
between active and inactive states [3, 112]. During the active state, the RNAP opens, allowing it
to bind the substrate: the correct NTP complementary to the nt on the DNA being transcribed
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[3, 112]. In the RNAPs catalytic site, a phosphodiester bond forms between the NTP and the
growing RNA. The by-product pyrophosphate is released and the newly bound RNA nt, along
with DNA, moves 1 nt relative to the RNAP, towards the RNA exit channel [10]. This process
continues until a terminator sequence is transcribed.
Intrinsic terminators halt transcription elongation independently of other molecules, whereas
rho-dependent terminators depend on a separate protein to terminate transcription. Intrinsic
terminators are made up of two sub sequences: a small hairpin followed by a sequence of 7 to
9 uracil (U) nucleotides [133], which form the terminator’s U-tract. According to one model of
intrinsic termination, the hairpin is transcribed first, but cannot form a secondary structure
within RNAP [133, 136]. Once transcribed, RNA in the nascent chain remains hybridized to
DNA for a period. U (RNA) and A (DNA) form the weakest base pair, so the weak hybridization
between the U-tract and DNA template causes transcription to pause, allowing the hairpin to
fold into its secondary structure [76]. The hairpin forms in the RNAP exit channel, causing the
RNA in the U-tract and DNA template to separate, thus terminating transcription [76].
There are several genetic parts that allow us to prematurely halt transcription elongation by
causing an intrinsic terminator to form in a transcript before a full coding sequence has been
transcribed. For example, small non-coding RNAs (ncRNA) can interact with a specific sequence
on the nascent mRNA strand. This interaction causes the RNA to form an intrinsic terminator
that halts transcription before the protein coding region of the gene can be transcribed. Examples
of devices that use this mechanism are RNA attenuators [84, 127] and Small Transcription
Activating RNAs (STARS) [28, 29]. RNA attenuator sequences, which occur in nature, are found
upstream of coding sequences. When an antisense small RNA (sRNA) is transcribed at the same
time as the attenuator, the sRNA interacts with the attenuator, causing the attenuator to fold
and form an intrinsic terminator (Figure 2.3) [11, 60]. Lucks et al. engineered a synthetic RNA
attenuator based on a naturally occurring system that repressed a gene by 87% when the sRNA
was highly expressed [84, 127] (Figure 2.3).
Chappel et al. developed a new class of regulator based on attenuators [28, 29]. In their new
system, an engineered terminator sequence is placed upstream of a gene of interest, containing a
sequence complementary to a STAR. When the STAR is absent the terminator forms, halting
transcription. However, when the STAR is present, it binds to the terminator sequence in the
mRNA, altering its secondary structure such that termination is bypassed (Figure 2.3B) [28, 29].
It has been shown that many orthogonal STARS can be designed using a computational approach
displaying up to a 9000-fold activation in the presence of their cognate STAR [29].
2.6 Tuning the rate of translation
The information encoded in a transcript is finally converted into a protein during the process
of translation. Translation is again made up of multiple steps. In bacteria, the first step is
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translation initiation where the 30S ribosomal subunit along with initiation factors bind to the
mRNA being translated, forming a 30S initiation complex (30SIC). Ribosomal RNA (rRNA) inside
the 30SIC forms hydrogen bonds with a specific sequence of mRNA directly upstream of the start
codon, contained within the RBS, known as the Shine–Dalgarno sequence (SD) [122, 141]. Next
a portion of the ribosomal subunit binds to a 3 nt sequence (the start codon - AUG), signifying
where translation of mRNA should start. Ribosomes then translocate 3 nt (a codon) at a time,
with each of 64 possible codons mapping onto one of the 20 canonical amino acids [111, 118]. Each
amino acid is attached to the growing nascent amino acid chain to produce a protein. Translation
initiation is often the rate limiting step in protein synthesis. When this is the case, the rate of
protein production will match the translation initiation rate [105].
A
B
Figure 2.3: Schematics of different RNA-based transcriptional regulatory mechanisms. (A) The
mechanism RNA attenuators use to regulate transcription (reprinted from Nucleic Acids Research, 41,
Takahashi & Lucks, A modular strategy for engineering orthogonal chimeric RNA transcription regula-
tors, 7577–7588, (2013) [127]) (B) The mechanism Small Transcription Activating RNAs (STAR) use to
regulate transcription (reprinted from Nat. Commun., 8, Chappell et al., Computational design of small
transcription activating RNAs for versatile and dynamic gene regulation, 1051, (2017) [29].)
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2.6.1 Modifying ribosome binding site strength
Translation is initiated at a rate related to the affinity that ribosomes have for the RBS. Several
molecular interactions between subunits of the ribosome and the RBS play a major role in
governing the rate of translation initiation. In the first step of translation initiation, the 16S
ribosomal RNA (rRNA), a component of the 30S subunit, hybridizes to the RBS [31]. The distance
between the 16S rRNA binding site and the start codon affects the translation initiation rate.
Secondary structures at or around the RBS also affect the rate of translation initiation [115].
Therefore, the translation initiation rate can be tuned by changing the sequence of the RBS in
relation to these various features.
Salis et al. built an equilibrium statistical thermodynamic model that predicts the translation
initiation rate for a RBS sequence based on the strength of binding between the RBS and the 30S
ribosome complex [115]. To validate how well the model predicted translation initiation rate based
on RBS sequence, a library of 28 existing RBSs was used to express a red fluoresecent protein
(RFP). There was a linear relationship between the predicted binding affinity (representative
of relative translation initiation rates) and fluorescence. The correlation, when fit using linear
regression, yielded a squared correlation coefficient (R2) of 0.54 [115]. Building on this, to
forward engineer novel RBSs, the thermodynamic model was coupled with a simulated annealing
optimization algorithm that predicts RBS sequences that have a specific binding affinity for
ribosomes that are closest to a user defined value. They used this approach to design 29 synthetic
RBSs that they used to drive RFP expression experimentally. Predicted binding affinities and
therefore relative protein production rates correlated well with fluorescence values (R2 = 0.84).
2.6.2 Regulating the rate of translation using RNA-based parts
Naturally occurring riboregulators form secondary structures near or around RBS sequences
to regulate the translation initiation rate of a gene [16, 17, 46, 53–55, 67, 68, 79, 88]. The
secondary structures in riboregulators vary in strength, allowing for the rate of translation to
be controlled over a wide range. In most riboregulators, a separate complementary antisense
RNA can hybridize with the riboregulator and affect the strength of the secondary structure
at the RBS [46, 79]. In some cases, antisense RNAs use this mechanism to reduce translation
initiation. For example, antisense RNAs can bind to riboregulators to form stronger secondary
structures around the RBS, causing a reduction in the rate of translation initiation. Conversely,
some antisense RNAs activate translation initiation, binding to their riboregulator and causing
them to lose their secondary structure. This enables ribosomes to access the RBS and increase
the translation initiation rate.
Isaacs et al. engineered the first synthetic riboregulator [68]. The first component is placed
upstream of the gene of interest. It is a 19 nt sequence that contains: the reverse complement of
the 5 nt found upstream of the RBS, the RBS sequence, and the 6 nt downstream of the RBS.
This sequence of RNA binds to the RBS and its flanking sequences, preventing ribosomes from
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binding to the RBS. The transcribed mRNA cannot be translated and so is called a cis-repressed
RNA (crRNA).
The second component is another RNA molecule called a trans-activating RNA (taRNA). The
taRNA contains the reverse compliment of the crRNA. When the crRNA is transcribed on its
own, ribosomes are blocked from the gene’s RBS, so the gene of interest is not translated. When
taRNA and crRNA are transcribed at the same time the taRNA binds to the crRNA and exposes
the RBS, activating translation (Figure 2.4A). Conversely, examples exist in nature where an
independent RNA molecule, or antisense RNA, represses translation of a gene of interest. In
these cases, the antisense RNA binds to the translation initiation site of the gene of interest,
blocking ribosomes from translating the gene [68].
An example of a riboregulator that is repressed by an antisense RNA is the RNA-IN-RNA-OUT
(RNA-IN/OUT) system. An antisense RNA sequence called the RNA-OUT contains a sequence
that is the reverse compliment of a regulating region of RNA upstream of the gene of interest
(RNA-IN) [23, 73, 86]. The translation initiation site, including the RBS and the start codon
(AUG), is contained within the RNA-IN sequence. When the gene of interest is transcribed on its
own, ribosomes can bind the translation initiation site and translate the gene of interest. When
RNA-OUT is transcribed at the same time, it binds the complimentary RNA-IN region blocking
ribosomes and thus, turning off translation of the gene.
Mutalik et al. built a library of synthetic RNA-IN/OUT pairs [98]. They made mutations to a
B
A
Figure 2.4: Schematic of how several RNA devices regulate translation. (A) Mechanism that
riboregulators use to regulate translation (reprinted from Cell, 159, Green et al., Toehold Switches:
De-Novo-Designed Regulators of Gene Expression, 925-939, Copyright (2014), with permission from
Elsevier). (B) Mechanism RNA-IN/OUT systems use to regulate translation (reprinted from Nat. Chem.
Biol., 8, Mutalik et al., Rationally designed families of orthogonal RNA regulators of translation, 447–454,
Copyright (2012), with permission from Springer Nature).
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wild type system and tested the binding of these variants in-vitro. They used the results of this
study to parameterise a model that allowed them to predict the behaviour of new sequences. They
then built and tested a large set of these variants to validate their model [98] (Figure 2.4B).
Both riboregulators [68] and RNA-IN/OUT systems [98] provide synthetic biologists with
parts to engineer more complicated genetic devices such as logic gates [16, 98]. Despite the clear
value of these devices, there are still problems with their designs. For example, both contain
sequences of RNA that bind directly to the RBS and start codon of the gene of interest. When
designing new riboregulators, their sequences must include all or part of the RBS sequence and
start codon. This puts a constraint on riboregulator design, limiting the number of functional
sequences that can be designed [59]. A second limitation is that the performance of these RNA-
based parts is normally relatively poor, with the fold-change between on and off states often much
less than 100-fold (less than 55-fold for synthetic riboregulators [17] and less than 10-fold for the
RNA-IN/OUT devices [98]).
Green et al. overcame these problems by engineering a new class of riboregulator called a
toehold switch (THS) [54, 55]. THSs do not include sequences of RNA that bind directly to the
RBS or a start codon in their design. They also give up to a 400-fold activation of gene expression.
The system consists of two components: the THS, a ~100 nt long sequence that forms a secondary
structure around a strong RBS to prevent translation and a sRNA, a ~65 nt long sequence that
binds to a complementary portion of the THS to activate translation.
Once a toehold switch is transcribed with its downstream gene, the switch RNA folds forming
a hairpin loop secondary structure that sequesters the RBS, preventing ribosomes from binding
it. Unlike previous riboregulators, the RBS is not bound by any bases in the secondary structure.
The switch RNA also contains a toehold, a single stranded overhanging sequence of RNA at the
bottom of the hairpin loop’s stem (Figure 2.5). When sRNA is transcribed at the same time as
switch RNA, it initially binds to the toehold, triggering a branch migration process that ends when
the sRNA binds to its complementary sequence in the switch’s stem. sRNA binding changes the
conformation of the THS’s secondary structure, exposing the RBS and enabling translation. The
relative concentration of trigger to switch RNA therefore determines the proportion of mRNAs
that can be translated. The amount of energy needed to unfold the hairpin loop of the switch
structure can be predicted using a thermodynamic model, opening up the ability to efficiently
design THSs computationally [54, 55].
2.7 Environmental conditions affect circuit performance
2.7.1 Circuit performance depends on the host
A genetic circuit’s performance can change depending on where it is used. The species or strain
of cell that acts as a host and environmental conditions such as temperature, concentration
of nutrients and oxygen all affect how biological parts in a circuit behave and thus its overall
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Figure 2.5: Mechanism toehold switches use to regulate translation. Switch RNA forms a sec-
ondary structure that prevents ribosomes binding the sequestered ribosome binding site (RBS) and start
codon (AUG) (reprinted from Cell, 159, Green et al., Toehold Switches: De-Novo-Designed Regulators of





























Figure 2.6: Schematic shows how environment and host interact with synthetic circuits. Ex-
pressing a synthetic circuit sequesters host resources needed for protein production, leaving fewer resources
for host function (green arrow). Grey arrows represent protein production.
function [21].
Gene’s that are part of a synthetic circuit rely on the host cell’s resources, such as RNAPs,
ribosomes and amino acids, to function. Different species and strains naturally produce different
amounts of these resources and alter their availability in response to changes in the environment.
As such, the rate that proteins used in circuits are produced will vary depending on the host cell
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and environment the circuit is used in. These contextual effects of the host and environment can
significantly impact the behaviour of genetic parts and cause circuits to behave unexpectedly and
even fail [21, 52] (Figure 2.6).
While the host can affect the function of a genetic circuit, a genetic circuit itself can affect the
host. For example, when non-native (heterologous) proteins are produced, they sequester shared
protein expression resources from the cell [57, 109, 135], reducing those available to carry out
essential functions, such as metabolism and cell maintenance. If this burden is significantly high,
genes associated with stress are activated. These genes have evolved to help organisms survive
harsh conditions, but come at the cost of often reducing gene expression globally. For example σ32
globally up-regulates transcription of many genes simultaneously during heat shock stress [113].
The global expression of this large set of genes sequesters resources needed to produce proteins,
further impacting the performance of any circuit present [27].
2.7.2 Circuit performance depends on environmental context
In addition to the effect of the host cell, circuit performance also varies depending on the
environment. This affects circuit performance in two major ways. First, it can impact host cell
physiology. Second, changes in the environment can directly affect the contents of the cell and
the essential chemical reactions of a circuit. For example, a small molecule might trigger a sensor
due to a similar chemical structure.
Factors such as temperature, nutrients and dissolved oxygen all change the rate that cells
grow at [52, 95]. Growth rate, in turn, affects the rates of cellular processes such as transcription
and translation [42]. Changes in the environment also cause the host cell to adapt for survival
[121]. For example, when E. coli cells grow in an environment with a limited amount of carbon,
proteins are produced that break down molecules made of carbon already found in the cell [140].
As well as affecting circuit performance by altering the host context, environmental conditions
directly affect how components in a circuit work. For example, the way that some parts perform
is directly dependent on temperature. DNA and RNA parts are often required to fold into specific
secondary structures which determine their function. Secondary structure is highly dependent
on temperature and so minor changes can have major affects on performance [30, 33].
2.7.3 Circuits perform differently in bioreactors
Parts used in genetic circuits are generally chosen based on characterisation data that provides
an input-output response function. This characterisation is often performed under homogeneous
lab conditions, at a temperature of 37 ◦C, in a low volume of nutrient rich media and with
high concentrations of dissolved oxygen [100]. This approach has its advantages. Characterising
components under standard conditions makes it easier to generate reproducible data and allows
components built in different labs to be easily compared. This expands the number of components
available to use in new designs. However, if these parts are used in conditions that differ from
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those used during characterisation, they will likely perform differently. This is problematic when
genetic circuits need to be used outside of the lab, where there is the possibility of exposure to a
large range of environmental conditions.
Genetic circuits can be used to engineer microbe strains that more effectively produce valuable
chemicals [95, 142]. Strains used to produce chemicals in industry are grown in bioreactors with
large volumes (up to 250,000 L for processes using bacteria), to improve the productivity of the
processes. When a production strain is being transferred from low volume lab scale to a large
scale reactor, problems often arise. Strains optimized for lab conditions, do not generally perform
well at industrial scales [80].
The reason for this is that within a bioreactor, growing cells are exposed to a wide range of
conditions. As the volume of a bioreactor increases, the amount of power needed to stir the reactor
becomes physically limited, resulting in the liquid culture not fully mixing [36, 58, 121]. In
comparison, the low volumes of liquid used to grow strains in the lab mix easily, so environmental
conditions are homogeneous and well-defined. Incomplete mixing in large bioreactors leads to the
formation of different compartments that do not mix with each other. This causes nutrients to
become localised and not distributed homogeneously [1] (Figure 2.7) .
Depending on the position of a compartment in a reactor, different environmental conditions
will be experienced. Temperature, concentration of substrate, concentration of dissolved oxygen
and pH will all vary. The differences in environmental conditions cause microbes to grow at
different rates and trigger different cellular responses as they adapt to the conditions [140].
A B C
Figure 2.7: Incomplete mixing in bioreactors causes compartments with different environ-
ments to form. (A) Photo of a bioreactor with 3 impellers. (B) Compartments in the bioreactor can be
seen in this 2-D laser visualisation of the bioreactor shown in panel A. (C) Solid particles are used to
emulate cells in a stirred tank reactor with single impeller. Brighter regions are regions of high particle
concentration which is analogous to high cell density (figures adapted from Alvarez et al., Chemical
Engineering Science 60:2449-2457 2005 [1]).
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Triggering these genes alters how cells metabolise nutrients and has a knock on effect on any
genetic circuits they harbor [36].
Cells cultured in a bioreactor will transition between these compartments, causing their
environmental conditions to vary over time. To illustrate this effect, Simen et al. exposed E. coli
cells to the conditions experienced in two different compartments [121]. Cells were grown in a
well-mixed reactor, abundant in nutrient. A fraction of the culture was continuously pumped into
a second reactor where cells were starved of a nutrient. This was done for two different nutrients:
glucose and ammonia. Passing cells between the two reactors emulated the passage they might
experience between two compartments within a large, poorly mixed bioreactor.
To assess the response of the cells, RNA sequencing was used. They found that depriving cells
of glucose or ammonia for just 110 s caused a notable stress response [121]. Genes transcribed
in response to a stress response signalling molecule, 5´-diphosphate 3´-diphosphate guanosine
(ppGpp), were up regulated in cells deprived of either glucose or ammonia. The ppGpp signal
triggers expression of genes associated with RNA synthesis and amino acids conservation [116].
In addition to these shared effects, short term ammonia starvation up regulated genes associated
with amino acid transport and biosynthesis [121] and glucose starvation down regulated genes
associated with nucleotide transport and metabolism [121].
Following on from this, Simen et al. explored how fluctuations in concentration of these
nutrients over a longer time scale affected cell physiology. Cultures were grown in the same two
reactor system for 28 hours and RNA sequencing was performed [121]. Cells circulated between
the main reactor and the secondary reactor where they were starved of either glucose or ammonia.
This replicates conditions in an industrial bioreactor, where cells constantly circulate between
different compartments. Cells that were intermittently starved of ammonia over 28 hours down
regulated genes associated with amino acid transportation and metabolism. Cells intermittently
staved of glucose up regulated genes associated with ppGpp.
To determine how fluctuations in environmental conditions affect circuit performance, we
must also consider how they affect gene expression in individual cells in an entire population
grown in a reactor. Delvigne et al. demonstrate this effect by showing that when cells are grown
in a bioreactor, there is a large variation in the growth rate of individual cells across a population
[36]. This variation in growth rate arises because the expression of genes becomes more stochastic
in the dynamic environment of an industrial bioreactor [36].
The current approach of designing and characterising genetic circuits in static lab environ-
ments clearly isn’t appropriate if industrial use is the goal. For genetic circuits to be of use in
industry they need to be robust and adaptable to dynamic environmental conditions.
2.7.4 Designing circuits for reactors
If we model the dynamic conditions in a bioreactor, we can build better models to predict how
genetic circuits will perform in real applications and improve their chance of effective scale-up.
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This is not a new idea, several groups have looked into the effect that different flow regimes in a
bioreactor have on the physiology of cells [36, 58, 121].
Haringa et al. modelled the movement of fluid in a bioreactor using computational fluid
dynamics (CFD). They coupled the CFD model with a metabolic model of the species Penicillium
chrysogenum, a fungus used to produce penicillin in industry [58]. This study predicted the
production rate of penicillin in varying reactor volumes and configurations and showed that
changing the configuration of the reactor can significantly alter the production rate of pencillin
between 18% and 50%. Whilst this study demonstrated how the dynamic environment of a
bioreactor can affect metabolism, the models used did not consider how changes in gene expression
due to stress responses might affect production rate. At this time, no such study has been made.
A novel approach for designing genetic circuits for industry would be to build on this work by
using a CFD model of a bioreactor alongside a model that captures the interaction between gene
expression and metabolism [102], enabling us to predict how a circuit might perform within this
environment.
An alternative approach is to design adaptable circuits that are more robust to changes in host
cell physiology. Ceroni et al. did this by building a genetic feedback controller that self-regulates
protein production in response to the burden it places on the shared resources of the host cell
[26]. First, they used RNA-seq to identify a promoter, PhtpG1, that becomes active when cells
were burdened. Next, they built a feedback controller that regulates expression of a burdensome
protein.
The controller uses CRISPRi to repress transcription of any burdensome protein by binding
to its promoter. Transcription of a sgRNA that targets the burdensome promoter is regulated
by PhtpG1, so when the cell is burdened, sgRNA is produced. The sgRNA along with dCas9,
which is constitutively expressed on the same plasmid, bind to and repress transcription at
the burdensome promoter. To test the controller, cells were cotransformed with the controller
and a burdensome plasmid which uses an arabonise inducible promoter (PBAD) to express the
large the violacein biosynthesis protein (VioB), fused to a fluorescent protein (mCherry). When
Viob-mCherry transcription was induced, it burdened the cell, which activated PhtpG1 and the
transcription of the sgRNA. sgRNA bound to dCas9 and the sgRNA-dCas9 complex targeted
and repressed PBAD , which reduced the rate of transcription of Viob-mCherry and therefore
burden. After 1 hour, cells with the controller produced protein at a rate >6–fold lower than cells
expressing Viob-mCherry without feedback, however, after 24 hours, cells with the the feedback
controller yielded 3.9 times more protein. This is largely due to the fact that cells harbouring the
feedback controller were healthier which allowed them to grow to a cell density >9–fold higher




Humans have harnessed biology to produce valuable chemicals for thousands of years. However,
technological innovations over the past century have given us more control over how we harness
it. By modifying the DNA of micoorganisms, we can engineer new strains to produce chemicals
more effectively. However, these developments are expensive. As such, the institutions that invest
in research and development expect innovations to lead to economic growth. This means strains
engineered using new technology must be more productive to ensure a return on their investment.
Innovations in biotechnology have resulted in new tools that biological engineers can use
to rationally engineer microbes; an entire new discipline called synthetic biology has emerged
as a result. Synthetic biologists use these enabling technologies with engineering principles to
rationally engineer systems of gene regulation.
Genes regulate many of the processes that occur within cells. By rationally engineering new
regulatory programs, synthetic biologists can more reliably control heterologous processes that
convert feed-stocks into valuable chemicals. By precisely regulating these processes they can
engineer strains that are more productive than those made using previous approaches.
Synthetic biologists often engineer gene regulation by considering gene regulatory networks
as circuits that execute a desired genetic program. Like electronic circuits, genetic circuits are
made up of parts and devices. Genetic circuits are designed by piecing together DNA parts and
then this DNA is placed in a living cell for execution and testing. If the circuit doesn’t behave as
intended, another iteration of design, build, test is performed until a working variant is found.
Whilst the tools used in synthetic biology are of great value, there are still many open
problems in the discipline that need addressing. In particular, reassembling circuits when they
fail is expensive and time consuming. Furthermore, even if a working circuit is found, lab
conditions do not generally mimic the diverse environments found in industrial processes. Thus,
many circuits break when scaled-up for industry. Tuneable genetic circuits offer a solution to both
these problems, allowing the function of genetic parts and devices to be dynamically modified
to suit their current conditions. Such circuits open up new avenues for robust and adaptive





In this chapter, we present the methods used to carry out the research presented in the rest of
the thesis. This covers the culturing and modification of the bacteria Escherichia coli (E. coli),
assembly and characterisation of genetic devices, modelling devices’ behaviours and the software
used in the research.
3.2 E. coli culturing and modification
3.2.1 E. coli strains
E. coli strain DH5-α (F −φ80dlacZ∆M15∆(lacZY A−argF)U169 recA1 endA1 hsdR17(r−k ,m+k )
phoA supE44 λ− thi−1 gyrA96 relA1) was used for cloning. E. coli strain BL21 Star (DE3) (F
–ompThsdSB (r−B,m
–
B) gal dcm rne131 (DE3)) (Thermo Fisher Scientific, C601003) was used
to characterize devices, unless otherwise specified.
3.2.2 Media
All water used to prepare media was ultra-purified using a water purifier (Merck-Millipore,
Milli-Q Integral ultrapure water type1). Lysogeny Broth (LB) (Miller) (10 g/L tryptone, 10 g/L
NaCl, 5 g/L yeast extract) (Sigma-Aldrich, L3522) and LB Broth (Miller) with agar (15 g/L agar,
10 g/L tryptone, 10 g/L NaCl, 5 g/L yeast extract) (Sigma-Aldrich, L3147) were used for cloning.
Dry media was dissolved in water then autoclaved at 121 ◦C for 15 min to sterilise.
Supplemented M9 minimal media (M9 media salts (6.78 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L
NH4Cl, 0.5 g/L NaCl; Sigma-Aldrich, M6030), 0.34 g/L thiamine hydrochloride (Sigma-Aldrich,
T4625), 0.4% D- glucose (Sigma-Aldrich, G7528), 0.2% casamino acids (Acros, AC61204-5000),
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2 mM MgSO4 (Acros, 213115000), and 0.1 mM CaCl2 (Sigma-Aldrich, C8106)) was used to
characterise devices unless stated otherwise. M9 salts were autoclaved at 121 ◦C for 15 min to
sterilise. All other components were sterilised by filtration using 0.22 µM sterile PES syringe
filters (Star Lab, E4780-1226). Antibiotics were added to media to select for resistance markers
in relevant plasmids.
3.2.3 Antibiotic stocks
To make antibiotic stocks, antibiotics solids were dissolved in ultra-pure water then sterile filtered
through 0.22 µM sterile PES syringe filters (Star Lab, E4780-1226). 1000x (50 mg/mL) ampicillin
trihydrate (Sigma, A1593-25G) and kanamycin sulfate (Sigma-Aldrich, K1637) were made and
stored at -20 ◦C. Stocks were thawed and diluted to working concentration (50ng/mL) for both
ampicillin and kanamycin.
3.2.4 Glycerol stocks
Glycerol stocks of bacteria strains were made by mixing overnight liquid culture with 60% (v/v)
glycerol, to give a final concentration of 20% glycerol, and placed in a -80 ◦C freezer.
3.2.5 Conditions for growing cells
Cells grown on agar plates were grown at 37 ◦C for 16 hours. Cells grown in liquid media were
grown in culture tubes at 37 ◦C and 250 RPM in an orbital shaking incubator (Stuart, SI500).
When cells were grown in 96 well plates, plates were covered with a breathable seal (Star Lab,
E2796-3015) and grown at 37 ◦C and 1250 RPM in a microtitre plate shaker incubator (Stuart,
SI505) for 16 hours when grown overnight, 3 hours when cells from overnight culture were
diluted and grown pre-induction or 5 hours when cells were induced.
3.2.6 Transformation of E. coli
To transform E. coli DH5-α cells we thawed a tube of competent cells on ice until defrosted
(around 10 min). 50 µL of thawed cells was pipetted into a microfuge tube then 1-5 µL of plasmid
DNA with a mass of 1 pg – 100 ng was pipetted into thawed cells. Cells were mixed by flicking
the tube 5 times. The cell and plasmid mix was incubated on ice for 30 min. Next, cells were
placed in a dry heating block (Thermo Fisher Scientific, 88870004) at 42 ◦C for 30 seconds then
incubated on ice for 5 min. 950 µL of SOC warmed to room temperature was added to the cells
which were then incubated at 37 ◦C with a rotation speed of 1250 RPM in a microtitre plate
shaker incubator (Stuart, SI505) for 60 min. 50 µL of transformed cells was pipetted onto an
agar selection plate and spread over the surface. The cells were incubated overnight at 37 ◦C. To
transform One Shot E. coli BL21 Star (DE3) cells (Invitrogen, C6010-03), the same procedure
was used, however, one tube of cells was thawed on ice and 1–5 µL of plasmid, at a concentration
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of 5–50 ng/µL was pipetted into thawed cells. Once the cells were transformed, 20 µL and 200 µL
of cells were pipetted and spread onto two separate selection plates. Plates were grown overnight.
3.3 Device construction
3.3.1 Plasmid sequences
Sequences for all plasmids built in this work can be found in Appendix A.1.
3.3.2 Genetic part sequences
Sequences for all genetic parts used in this work can be found in Table A.1.
3.3.3 Plasmid preparation
Cells picked from single colonies on agar plates were used to inoculate 5 mL of media. Cells in
liquid culture were grown for 16 hours at 37 ◦C at 250 RPM in an orbital shaking incubator
(Stuart, SI500). 4 mL of cells were spun down for plasmid preparation. All plasmid preparation
was performed using the NEB Miniprep kit (New England Biolabs, T1010S) and the standard
protocol for the kit.
3.3.4 Polymerase chain reaction
Polymerase chain reactions (PCRs) were performed in a thermal cycler (Applied Biosystems,
SimpliAmp). Components were gently mixed before placing in the thermal cycler. NEB Phusion
high-fidelity DNA polymerase (New England Biolabs, M0530) was used to PCR fragments for
cloning, using the standard protocol. Components show in Table 3.1 were assembled on ice and
PCR was performed with the thermal cycler routine shown in Table 3.2. Colony PCRs were
performed using Quick Load Taq polymerase (New England Biolabs, M0271L) with its standard
protocol. Reaction components shown in Table 3.3 were assembled on ice before being transferred
to the thermal cycler, where the routine shown in Table 3.4 was used.
3.3.5 Gibson assembly
Gibson assembly was used to build plasmids containing the tuneable expression system (TES)
(pVB001) and the tuneable NOT gate (pVB002) with the RiboJ insulator. It was performed using
NEB Gibson Assembly Master Mix (New England Biolabs, E2611S). Components listed in Table
3.5 were assembled on ice. 50-100 ng of linearized vector with a mass of insert 2-3 times that of
the vector was used. For inserts less than 200 bps, 5-times the mass of the vector was used. The
total volume of PCR fragment used in the reaction was less than 20% of the total volume of the
reaction. Samples were incubated in a thermal cycler at 50 ◦C for 15 min when 2-3 fragments
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Table 3.1: Reaction components for polymerase chain reaction with Phusion polymerase
Component 25 µL Reaction Final Concentration
Nuclease-free water To 25 µL
5X Phusion GC buffer 5 µL 1X
10 mM dNTPs 0.5 µL 200µM
10 µM Forward Primer 1 µL 0.5 µM
10 µM Reverse Primer 1 µL 0.5 µM
Template DNA Variable 1 pg to 10ng
Phusion DNA Polymerase 0.25 1.0 units/50 µL PCR
Table 3.2: Thermal cycler routine for polymerase chain reaction with Phusion polymerase
Step Temperature ◦C Time







15-30 seconds per kb
Final Extension 72 ◦C 5-10 min
Hold 4 ◦C
Table 3.3: Reaction components for polymerase chain reaction with Quick-Load Taq polymerase
Component 25 µL Reaction Final Concentration
Nuclease-free water To 25 µL
10 µM Forward Primer 0.5 µL 0.2 µM
10 µM Reverse Primer 0.5 µL 0.2 µM
Template DNA Variable < 1000 ng
Quick-Load Taq 2X Master Mix 12.5 µL 1X
were used or 60 min for 4-6 fragments. After incubation, plasmids for transformation were stored
at -20 ◦C. Plasmids were transformed into DH5-α competent cells as outlined in section 3.2.6.
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Table 3.4: Thermal cycler routine for polymerase chain reaction with Quick-Load Taq polymerase
Step Temperature ◦C Time







1 minute per kb
Final Extension 68 ◦C 5 min
Hold 4 ◦C
Table 3.5: Reaction components used in gibson assembly
2-3 Fragments 4-6 Fragments
Total amount of fragments X µL of 0.02-0.5 pmols X µL of 0.2-1 pmols
Gibson Assembly Master Mix (2X) 10 µL 10 µL
Deionized water 10 - X µL 10 - X µL
Total Volume 20 µL 20 µL
Table 3.6: Reaction components used in golden gate assembly
Assembly Reaction
Backbone, 75 ng/µL 1 µL
Inserts 2:1 Molar ratio
T4 DNA Ligase Buffer (10X) 2 µL
NEB Golden Gate Assembly Mix 1-2 µL
Nuclease-free water to 20 µL
3.3.6 Golden gate assembly
Golden gate assembly was used to remove the RiboJ insulator from the TES and NOT gate
plasmids, yielding plasmids pVB003 and pVB004, respectively. Golden gate assembly was per-
formed using the NEB Golden Gate Assembly Kit (BsaI-HF®v2) (New England Biolabs, E1601).
Components listed in Table 3.6 were assembled on ice. Components were incubated in a thermal
cycler at 37 ◦C for 5 min, then heated to 60 ◦C and incubated for 5 min, to allow for the digestion
of any remaining BsaI sites. Assembled plasmids were transformed into DH5-α competent cells
as outlined in section 3.2.6.
31
CHAPTER 3. MATERIALS AND METHODS
3.3.7 Gel electrophoresis
Gel electrophoresis was used to quality control products from PCRs and assembly methods and
verify that they yielded DNA products with expected lengths. To prepare a 1% agarose gel for use
in a 20 mL chamber, a screw top bottle was loaded with 0.2 g of agarose (Lonza, 98200-100) and 20
mL of TAE buffer diluted with SYBR Safe (Thermo Fisher Scientific, S33102) to 1X concentration
from a 10,000X concentration stock. The lid was screwed on and the bottle was shaken to dissolve
agarose. The lid was undone half a turn before microwaving the agarose at 800 W for 30 seconds.
The bottle was swirled to ensure agarose was well mixed before microwaving at full power for
another 30 seconds. The contents of the bottle were swirled once more then the liquid agarose
was poured into a 20 mL gel casting tray with appropriate well comb inserted and left to set for
40 min at room temperature.
DNA samples were prepared by mixing 5 µL of DNA in elution buffer, containing 2–20 ng/L
of DNA, with 1 µL of 6 X purple no SDS gel loading dye (New England Biolabs, B7025S). The
gel in its casting tray was moved into a gel box (Bio-Rad, Mini-Sub Cell GT). The well comb was
removed then the gel box was filled with TAE buffer until buffer height was slightly higher than
the surface of the gel. Using a pipette, DNA was loaded into relevant wells. The gel box lid was
put on and connected to a power pack (Bio-Rad, PowerPac Basic). Gels were run at 300 V with a
constant 80 mA current for 30 min. Gels were visualised and photographed on a gel doc (UVP,
BioDoc-It).
3.3.8 Tuneable expression system assembly
The tuneable expression system was assembled into the plasmid pVB001 (Figure 3.3). It was
built from 3 linear DNA fragments assembled using Gibson assembly (Figure 3.1). The first
fragment, an expression cassette for small RNA (sRNA) 20 [55] was amplified from a synthesized
DNA block – VB_TS_ASS_B (Table 3.7) (Thermo Fisher Scientific, GeneArt), using primers
PVB_1_TES_fwd and PVB_2_TES_rev to give a 183 bp sequence containing Ptac, sRNA-20 and
terminator L3S3P11. The second fragment was amplified from a second synthesized DNA block –
VB_TS_ASS_A (Table 3.7) (Thermo Fisher Scientific, GeneArt) using primers PVB_3_TES_fwd
and PVB_4_TES_rev. The resulting fragment was a 241 bp sequence containing Ptet, insula-
tor RiboJ and toehold switch-20 [55]. The third fragment was amplified from circuit plasmid
pAN1720 [100] with primers PVB_5_TES_rev and PVB_6_TES_FWD to make a 5760 bp lin-
earized backbone containing kanR, p15A ORI, tetR, lacI, araC and yfp. Primer sequences with
annealing temperatures and extension times are shown in Table 3.8. Primers introduced a
17 to 21 bp overhang sequence homologous to sequences at the end of fragments that would
be adjacent in the final construct, allowing the plasmid to be assembled via Gibson assembly.
After assembly, DH5-cells were transformed with reaction product and grown overnight on a
selection plate. Six colonies were tested using colony PCR with Quick Load Taq polymerase

































Figure 3.1: Tuneable expression system assembly Green and red half arrows show where forward
and reverse primers bind to template DNA. All primers contain overhang sequences. During PCR-1
fragment–1, containing Ptac small RNA (sRNA) and terminator L3S3P11 was amplified from synthesized
DNA block VB_TS_ASS_A. During PCR-2, fragment–2, containing Ptet, RiboJ insulator and toehold switch
(THS) DNA fragment were amplified out of the synthesized DNA fragment VB_TS_ASS_B. During PCR-3,
fragment-3 (the plasmid backbone) was amplified from plasmid pAN1720, removing the PBAD promoter.
Fragments are shown here in the order they were inserted into the backbone during Gibson Assembly.
Colonies containing plasmids that yielded fragments of the correct length were grown overnight
in liquid media before being prepared (as outlined in section 3.3.3), and sent for sequencing using
sequencing primers pSeq1_TES and pSeq2_TES (Table 3.8).
3.3.9 Tunable NOT gate construction
The tuneable genetic NOT gate plasmid, pVB002 (Figure 3.3) was assembled from 4 linear
fragments using Gibson assembly (Figure 3.2). To produce fragment-1, pAN3938 [100] was used
as a template for primers PVB_3_TES_fwd and PVB_4_TES_rev. The PCR yielded a 690 bp
sequence containing PhlF and Terminator ECK120033737. To produce fragment-2, pAN4036
[100] was used as template with primers PVB_P5_NOT_fwd and PVB_P6_NOT_rev to amplify a
98 bp fragment containing a spacer and the PphlF promoter. To produce fragment-3, pAN4036
[100] was used as a template with primers PVB_P7_fwd and PVB_P8_rev to amplify a 917
bp sequence containing insulator RiboJ, RBS B0064, yfp and Terminator L3S2P2. To produce
fragment-4, yfp and its terminator, L3S2P21 were removed from pVB001 by PCR, using primers
PVB_P1_NOT_fwd and PVB_2_TES_rev, yielding a linearized 5379 bp fragment containing: Ptac,
sRNA-20, terminator L3S3P11, Ptet, insulator RiboJ and toehold switch-20. Primers and PCR
conditions are shown in Table 3.8. Primers were designed to flank fragments with 13 to 21
bp overhang sequences. Overhang sequences were homologous to overhangs on fragments that
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would be adjacent in the final construct which allowed the plasmid to be assembled via Gibson
assembly (Section 3.3.5).
Assembled plasmids were transformed into DH5-α cells. 12 colonies were grown overnight and
screened using the standard device characterisation protocol (section 3.4.5) in four combinations
of aTc and IPTG (aTc: 0 ng/mL , IPTG: 0 µM; aTc: 0 ng/mL , IPTG: 1000 µM, aTc: 50 ng/mL,
IPTG: 0 µM; aTc: 50 ng/mL, IPTG: 1000 µM). Colonies containing plasmids that showed NOT
gate behaviour, i.e. had a considerably higher output fluorescence in an OFF state (aTc: 0 ng/mL ,
IPTG: 0 M) than an ON state (aTc: 50 ng/mL, IPTG: 1000 M) were prepared then sequenced with







































Figure 3.2: Tuneable NOT gate system assembly Schematic shows 4 PCR reactions used to amplify
the fragments used to assemble the tuneable NOT gate plasmid (pVB002). Green and red half arrows
show where forward and reverse primers bind to template DNA. Dotted box shows DNA removed from
fragments and solid lined boxes show DNA amplified out of fragemetns. (PCR-1) Fragment-1, the PhlF
open reading frame and terminator were amplified out of plasmid pAN3938 [100]. (PCR-2) Fragment-2,
a spacer followed by PphlF was amplified out of plasmid pAN4026 [100]. (PCR-3) Fragment-3, a YFP
cassette was amplified out of plasmid pAN4026 [100]. (PCR-4), Fragment-4 (Backbone), a YFP cassette was
removed from plasmid pVB001, yielding the linearized backbone used for assembly. Overhangs flanking
fragments were homologous to adjacent fragments in the final construct allowed the plasmid, pVB002 to
be assembled using Gibson assembly. Fragments are shown here in the order they were inserted into the
backbone.
3.3.10 sRNA booster plasmid construction
The booster plasmid, pVB005 (Figure 3.3), used to increase the rate of transcription of sRNA
was fully synthesized (Thermo Fisher Scientific, GeneArt). It contained an sRNA expression
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All sequences are written from 5’ to 3’.
cassette, a 133 bp sequence made up of PT7, sRNA-20 and a T7 terminator. The backbone of the
plasmid contained an ampR ampicillin resistance cassette and a pColE origin of replication.
3.3.11 Removal of RiboJ insulators
RiboJ insulators were removed from the TES (pVB001) and NOT gate (pVB002) plasmids by
amplifying the plasmids using forward and reverse primers upstream and downstream of the
RiboJ sequence, respectively so that the linear backbone product did not contain the RiboJ
sequence. Primers used in the PCRs (primers pF-RemRiboJ-THS20 and pR-RemRiboJ-THS20,
Table 3.8) introduced BsaI sites and 4bp overhang sequences to either end of the linearized
fragments. Overhangs were complimentary to overhangs on the opposite ends of the plasmid. This
allowed us to perform a one pot Golden Gate reaction. Plasmids were sequenced using primers
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Figure 3.3: Plasmid maps. (A) pVB001: tuneable expression system. (B) pVB002: tuneable NOT gate.
(C) pVB003: tuneable expression system without RiboJ insulator. (D) pVB004: tuneable NOT gate without
RiboJ insulator. (E) pVB005: tuner sRNA booster.
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pSeq1_TES, pSeq2_TES for the TES (pVB003) and pSeq1_TES, pSeq2_TES and pSeq3_NOT for
the NOT gate (pVB004) (see Table 3.8).
3.3.12 Sequence verification
Plasmids were sequence verified using sanger sequencing (Eurofins Genomics). Sequencing
primers used are shown in Table 3.8.
3.4 Characterising devices
3.4.1 Inducing circuits for characterisation
Single colonies from streaked plates were used to inoculate 200 µL of supplemented M9 minimal
media with relevant antibiotic in a 96 well plates then grown overnight at 37 ◦C with a rotation
speed of 1250 RPM in a microtitre plate shaker incubator (Stuart, SI505). 15 µL of the overnight
culture was loaded into 185 µL of supplement M9 media. 15 µL of these diluted cells were then
used to inoculate 185 µL of supplement M9 media with relevant antibiotic. Cells were grown
for 3 hours, after which they were diluted 3-fold in M9 media with relevant antibiotic. 10 µL of
diluted cells was used to inoculate wells loaded with 140 µL of M9 media with relevant antibiotic
and inducer. For all characterizations, wells were loaded with different combinations of IPTG
and aTc. For the TES, wells were loaded with combinations of IPTG (at final concentrations: 0,
10, 20, 45, 70, 100 and 1000 µM) and aTc (at final concentrations: 1, 2, 4, 8 and 50 ng/mL). For
the NOT gate wells were loaded with combinations of IPTG (at final concentrations 0, 10 , 20, 45,
70, 100 and 1000 µM) and aTc (at final concentrations 0.01, 0.04, 0.14, 0.5 and 2 ng/mL). Cells
were grown in 96 well plates for 5 hours before being prepared for flow cytometry.
3.4.2 Flow cytometry
Phosphate buffer saline (PBS) solution was made by dissolving a PBS tablet (Gibco, 18912014) in
500 mL of ultra-purified water which we autoclaved at 121 ◦C for 15 min to sterilise. In a 50 mL
falcon tube 12.3 mL of PBS was mixed with 600 µL of kanamycin (50 mg/mL stock), to give a final
kanamycin concentration of 2mg/mL. 90 µL of PBS mixed with kanamycin was loaded in to every
well of a 96 well plate. Cells in the 96-well plate they were grown in were mixed by pipetting
then loaded into the 96-well plate containing PBS and kanamycin. These were then mixed with
the PBS by pipetting to fix them. YFP fluorescence of individual fixed cells was measured using
an Acea Biosciences NovoCyte 3000 flow cytometer equipped with a NovoSampler to allow for
automated collection from 96-well microtiter plates. Cells were excited using a 488 nm laser and
measurements taken using a 530 nm detector. A flow rate of 40 µL/min was used to collect at least
100,000 cells for all measured conditions. Automated gating of events using the forward (FSC-A)
and side scatter (SSC-A) channels was performed for all data using the FlowCal Python package
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Table 3.8: List of primers used for plasmid assemblies, sequencing and colony PCR





PVB _1 _TES _fwd TES assembly ctaacggggggcctttttttgAACGATCG
TTGGCTGTGTTG
66 15
PVB _2 _TES _rev TES assembly aaagccaacggtggagtaGGTAGACCAG
AAACAAAAAAACACCC
66 15
PVB _3 _TES _fwd TES assembly gtgtttttttgtttctggtctaccTACTCCACC
GTTGGCTTTTTTCC
72 15
PVB _4 _TES _rev TES assembly tcctcgcccttgctcacTTTACGCATCTTT
TGCGCTGC
72 15
PVB _5 _TES _rev TES assembly caacacagccaacgatcgttCAAAAAAAG
GCCCCCCGTTAG
66 30
PVB _6 _TES _fwd TES assembly cagcgcaaaagatgcgtaaaGTGAGCAA
GGGCGAGGA
66 30
PVB _P1 _NOT _fwd NOT assembly ttcgttttggtccAGTTTACGGCTAGCT
CAGTCCTAG
63 81
PVB _P2 _NOT _rev NOT assembly gctacggctcggggtacgtgcTTTACGCAT
CTTTTGCGC
63 81
PVB _P3 _NOT _fwd NOT assembly tgcgtaaagcacgtaccccgaGCCGTAGC
AGCATTGGTAG
63 15
PVB _P4 _NOT _rev NOT assembly ttccaccgtacgtcgaaCGTTGACACCT
TTGGTCG
63 15
PVB _P5 _NOT _fwd NOT assembly caaaggtgtcaacgTTCGACGTACGG
TGGAATC
63 15
PVB _P6 _NOT _rev NOT assembly atccggtgacagcttGACCTTAACGAT
ACGGTACGTTTC
63 15
PVB _P7 _NOT _fwd NOT assembly taccgtatcgttaaggtcAAGCTGTCAC
CGGATGTG
63 15
PVB _P8 _NOT _rev NOT assembly tgagctagccgtaaactGGACCAAAAC
GAAAAAGGC
63 15
pF-RemRiboJ-THS20 RiboJ Removal cgaaggtctcaGGGCGTTAATCT CTG-
GCTTGCTTTATG
60 90
pR-RemRiboJ-THS20 RiboJ Removal ggtcggtctcagcccGTGCTCATTATC
TCTATCACTGATAGGGATGTC
60 90




pSeq2 _TES TES and NOT
gate sequencing
CAGGAGCGCACCATCTTCTTC
pSeq3 _NOT NOT sequenc-
ing
CGTTGTGTTATTGCAGAAG
Underlined sequences are overlapping sequences used for assembly, lower case bases are bases introduced
by the primer through PCR. Bold text is the BsaI recognition site needed for Golden Gate Assembly. All
sequences are written from 5’ to 3’.
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version 1.2 [25] and the density2d function with parameters: channels = [‘FSC-A’, ‘SSC-A’], bins =
1024, gate_fraction = 0.5, xscale = ‘logicle’, yscale = ‘logicle’, and sigma = 10.0.
3.4.3 Plate reader assay
Cells were grown overnight in LB media (for 16 hours) at 250 rpm in culture tubes. 10 µL of
overnight culture was used to innoculate 140 µL LB media with the desired concentration of
inducer into a black 96 well plate with optically clear flat bottomed wells (Brooks Life Sciences,
4ti-0223). Wells were loaded with combinations of IPTG (at final concentrations: 0, 18, 90, 200,
300 ,450, 670 and 1000 µM) and aTc (at final concentrations: 0, 0.04, 0.25, 0.63, 1.0, 1.6, 2.1, 4.0
ng/mL). OD600 and fluorescence (at excitation wavelength 512 nm and emission wavelength 529
nm) were measured from the top and bottom of each well every 16 min, respectively.
3.4.4 Autofluorescence normalisation
Plasmid pAN1201 [100] was used to measure autofluorescence. pAN1201 had the same backbone
as we used to test the devices and like the device plasmids, it contained a constitutively expressed
KanR, and TetR and LacI regulated by a PlacI promoter but no YFP casette. We transformed
pAN1201 into E. coli BL21 star (DE3) and grew cells in the same conditions as our devices. The
fluorescence of the autofluorescence strain was measured using flow cytometry (section 3.4.2).
The fluorescence we detected in cells transformed with pAN1201 was the autofluorescence of
the cells. We calculated the median fluorescence of three gated populations of cells containing
pAN1201 and took the mean of these values. This value was then subtracted from the median
fluorescence of our devices to give an autofluorescence normalised fluorescence.
3.4.5 Characterising sensor outputs in relative promoter units
To relate the sensor inputs (concentrations of inducer), to their outputs (promoter activities),
which are our device inputs , the outputs from sensors Ptet and Ptac were characterised using
sensor characterisation plasmids pAN1718 and pAN1719, respectively [100]. These plasmids
used the same backbone as our devices and contained their respective sensor upstream of the
same YFP cassette (RiboJ, RBS–B0064, yfp, terminator–L3S2P21). Output fluorescence from a
third plasmid (pAN1717) that used the same YFP casette regulated by a constitutive promoter
(J23101), was used as reference to convert the output from the sensors (fluorescence data in
arbitrary units – a.u) into relative promoter units (RPU). All plasmids were transformed into
cells and grown in the same way as our devices. Cells containing pAN1718 ( Ptet) were grown
in aTc concentrations: 0, 0.01, 0.04, 0.14, 0.5, 1, 2, 4, 8, 50 ng/µL. Cells containing pAN1719
(Ptac) were grown in IPTG concentrations: 0, 0.5, 5, 50, 100, 200, 450, 1000, 4000, 16000 mM.
Cells containing pAN1717 were grown in no inducer. For each set of strain and condition, three
biological replicates were performed. Fluorescence was measured using flow cytometry and the
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median fluorescence of gated populations for replicates was averaged. We standardised the output
promoter activities by converting them from fluorescence into relative promoter units using:
RPU = 〈Y FP〉−〈Y FP〉0〈Y FP〉RPU −〈Y FP〉0
(3.1)
where 〈Y FP〉 is the median fluorescence of the device being measured, 〈Y FP〉RPU is the median
fluorescence of cells transformed with the RPU plasmid and 〈Y FP〉0 is the median fluorescence of
cells transformed with an autofluorescence control. We plotted promoter outputs in RPUs against
inducer concentrations to make a calibration curve (Figure 4.6), which was used to convert
sensor input concentrations into promoter activities in RPUs.
3.4.6 Calculating intersection
For two overlapping population distributions, the fraction of individual cells from each distribution







where H(x, y) is the intersection between distributions x and y. Distributions x and y are divided
into n bins that correspond to identical ranges of values, with xi and yi denoting the value of bin
i for distributions x or y, respectively [126].
3.4.7 Computational analyses and response function fitting
Data analysis was performed using custom software written in Python version 3.6.6. Response
functions for the tuneable expression system were fitted to the hill function:
y= ymin + (ymax − ymin) x
n
Kn + xn , (3.3)
where y is output YFP fluorescence (in arbitrary units), ymin and ymax are the minimum and
maximum YFP fluorescences (in arbitrary units), x is the input promoter activity (in RPU), K is
the input promoter activity at which the output is at half of its dynamic range (i.e.ymin +0.5×
(ymax − ymin), in RPU) and n is the hill coefficient. Response functions for the NOT gate were
fitted to the hill function:
y= ymin + (ymax − ymin) K
n
Kn + xn . (3.4)




3.4.8 Finding growth rates




where t is time, y is cell density, a, b and n are empirical growth coefficient parameters [35].
The maximum growth rate was found using numerical differentiation on the curve fit using the
numpy gradient function in Python version 3.6.6. The maximum gradient was the value taken as
the maximum growth rate.
3.5 Modelling
3.5.1 Numerical simulations
Deterministic ordinary differential equation models were simulated using COPASI version 4.2.4
using a parameter scan that implemented a ‘steady-state’ task with default parameters [63] .
Stochastic simulation of the biochemical models were carried out in COPASI using the tau-leap
method, starting in steady state with settings: duration = 100 min, interval size = 1 min, number
of intervals = 100 [63].
3.5.2 Fitting model with particle swarm optimisation
Parameterization was performed using custom software built in Python. Initial estimation was
performed using parameters shown in Table 4.1. The scipy integrate package was used to solve
the model with the integrator set to "vode", which uses an implicit Adams method to solve
non-stiff problems and a backward differentiation formula method to solve stiff problems. For
each input combination, the simulated trajectory for the dynamics of protein production was
compared to the experimental data using least squares regression, which acted as the objective
function for the optimization. A particle swarm optimization algorithm implemented in python
with the pyswarm package with parameters: maxiter=100, args=dataSet, omega=0.5, phip=0.7,
phig=0.4, swarmsize = 200, was used to minimize the objective function.
3.5.3 Predicting RNA binding and secondary structure
NUPACK version 2.2 v was used to simulate RNA binding and secondary structure. We simulated
folding of a toehold switch (switch) and cleaved RiboJ bound to switch (cRiboJ-Switch), with
parameters: nucleic acid=RNA, temperature=37◦C, strand species = 1 and a maximum complex
size = 1. The concentration of toehold switch mRNA was set to 5×104µM.
Binding and folding of the toehold switch with trigger sRNA (trigger) and cRiboJ-switch with
trigger sRNA were simulated using parameters: nucleic acid = RNA, temperature = 37◦C, strand
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All sequences are written from 5’ to 3’.
species = 2 and a maximum complex size = 2. The concentration of toehold switch mRNA and
tuner sRNA were set to: 5×104 µM and 7×105 µM, respectively. Sequences used in simulations
can be found in Table 3.9.
3.5.4 Predicting RNA folding speeds
Speed of RNA folding was predicted using Kinfold (Vienna-RNA-package version 1.4 [45])
with the following parameters – energy model: dangle=2, Temp= 37.0◦C, logML=logarithmic,
Par=VRNA–1.4; move set: noShift=off, noLP=off ; simulation: num=1, time=500.00, seed=clock,
fpt=on mc=Kawasaki, phi=1, pbounds=0.10.12; Output: log=kinout, silent=off, lmin=off, cut=20.00
[45]. We simulated folding speeds for a toehold switch, a toehold switch with an upstream RiboJ
(RiboJ-Switch) and a toehold switch with an upstream cleaved RiboJ (cRiboJ-Switch). Sequences
used for simulations can be found in Table 3.9.
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3.6 Data analysis software
Custom software to analyse experimental data and generate plots was written in Python version
3.6.6. Matplotlib version 3.1.1 was used to generate plots. Scipy version 1.3.0 was used with





A tuneable expression system
4.1 Introduction
Synthetic circuits have been shown to improve the production of valuable chemicals [48, 96].
Industrial production of valuable chemicals happens in bioreactors, where cells are grown in
dynamic environments in which conditions such as temperature and concentration of nutrient
change across the volume of the reactor as well as over time. These variations in conditions
affect how parts and devices behave [52, 95]. Therefore, changing environmental conditions can
change the shape of response functions, causing devices to become mismatched and circuits to
fail. Broken devices and circuits must be rebuilt and tested, which is costly and time consuming.
Here, to address this problem we designed a tuneable expression system (TES) whose response
function can be dynamically tuned by simultaneously controlling the rates of transcription and
translation of a gene of interest. Using a TES removes the need to rebuild circuits when they
fail. Instead, the TES can be used to tune the behaviour of individual parts until a working
combination is found. This approach allows us to bypass the expensive and time consuming task
of assembling new genetic designs from scratch for each DBTL iteration.
In Section 4.2 we define the tuneable expression system (TES) and derive a deterministic
ordinary differential equation (ODE) model that we use to predict the device’s behaviour. Then,
in Section 4.3 we design a TES from real genetic parts. We adapt the parameters in our model
to make them realistic for these parts, and use this model to predict the behaviour of the
potential TES implementation. Following on from this we built the TES and characterised it
in-vivo. We present results from experiments in Section 4.4 which showed that tuning the device
adversely affects performance and we suggest potential causes of these effects. In Section 4.5,
we characterise the dynamics of protein production by the TES and finally in Section 4.6 we
summarise our findings and discuss potential improvements to the design.
45
CHAPTER 4. A TUNEABLE EXPRESSION SYSTEM
4.2 A simple motif for gene regulation
The TES is a simple genetic regulatory motif whose steady state response function can be tuned.
The motif has two inputs. A main input regulates transcription of the gene of interest whilst
the second tuner input modifies the output relative to the input. By modifying the tuner, the




Figure 4.1: Systems Biology Graphic Notation (SBGN) diagrams of tuneable expression sys-
tems (TES). SBGN diagram of a TES. A tuner chemical species modifies the reaction producing mRNA,
the reaction converting mRNA into protein, or modifies the protein itself in order to tune protein produc-
tion.
4.2.1 A small RNA regulated tuneable expression system
We developed a general device that implemented the TES motif. The input to the device is the
activity of an input promoter that regulates the rate of transcription of a gene of interest, where
promoter activity is the flux of RNAP at the promoter. Increasing the input promoter activity
increases the rate of transcription of the gene of interest and therefore the concentration of
mRNA produced, which in turn increases the rate of translation and therefore the devices output
which is the rate of protein production. The relationship between the devices input and output
is captured in its response function. By using promoter activity as the device’s input, any other
device that uses a promoter as its output can be used to regulate the input, allowing the device to
be more easily integrated into larger circuits [100].
To tune the response function, the TES uses a second mode of gene regulation to modify
the rate of protein production, so that at any input promoter activity, the output can be tuned,
allowing us to change the shape of the TESs response function. For example, the rate of induced
premature transcription termination [28, 29, 84, 127], translation [16, 17, 54, 55, 68] or protein
degradation could be used as a second mode of gene regulation. Whilst we could use many modes of
gene regulation to vary the rate of protein production, we focused on designing a device that uses
small RNAs (sRNA) to modify the rate of protein production [16, 17, 28, 29, 54, 55, 68, 84, 127].
We chose this class of regulator because: producing sRNAs in cells is not resource intensive, many
sRNA devices perform well, some can be designed to respond to endogenous genes in a host,
they encompass a wide range of mechanisms for regulating gene expression and many can be
predictably designed computationally because RNA thermodynamic models accurately capture
their behaviour.
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Figure 4.2: Systems Biology Graphic Notation (SBGN) diagram of a sRNA tuneable expression
system (TES). SBGN schematic of a TES. Small RNAs (sRNA) modify the rate of protein production.
Small squares represent processes, circles with circles inside represent the dissociation of bound molecules,
black filled circles represent the association of molecules.
The precise mechanism that sRNA devices use to regulate protein production varies between
system. In general, sRNAs interact with mRNA in such a way that alters the effective concentra-
tion of mRNA that can be translated, thus modifying the rate of protein production. sRNAs can
either interact with mRNAs to increase or decrease the concentration of translatable mRNAs,
which results in systems that increase or decrease the rate of protein production in response
to increasing rates of sRNA transcription. We focused on sRNA devices that activate protein
production in response to sRNAs. The rate of transcription of the sRNA tuner molecule was
regulated by the activity of a second promoter – the tuner input Figure 4.2.
4.2.2 Modelling a small RNA tuned tuneable expression system
The TES activates protein production in response to sRNAs associating with the mRNA, so toehold
switches (THS) [55] or synthetic riboregulators [16, 17, 68] could be used to tune translation. We
assume that the sRNA and mRNA associate and dissociate in a reversible process.
Based on reactions between significant biochemical species in the TES we built an ODE model
that would allow us to predict how a TES design would behave. We considered reactions involving
four biochemical species in the TES:
rM−−→ M , (4.1)
rS−→ S , (4.2)
M+S k
+
C−−→ C , (4.3)
C
k−C−−→ M+S , (4.4)
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M, S, C and P are the concentrations of : mRNA containing a transcription regulating region
of RNA followed by the open reading frame of a gene of interest, sRNA used to tune rate of protein
production, complex formed between M & S and protein, respectively. M and S are transcribed
at rates of rM and rS. mRNA and sRNA bind to form a complex at a rate of k+C MS. Complex
dissociates into mRNA and sRNA a a rate of k−CC and mRNA is translated into protein at a rate
of rP . mRNA, sRNA, complex and protein degrade at a rate proportional to their concentrations
and rate constants: γM , γS, γC and γP respectively.




= rM −k+C MS+k−CC−γM M , (4.10)
dS
dt
= rS −k+C MS+k−CC−γSS , (4.11)
dC
dt
= k+C MS−k−CC−γC , (4.12)
dP
dt
= βCC−γP . (4.13)
4.3 Design and modelling of a tuneable expression system
4.3.1 Design and biological implementation of a tuneable expression system
We designed a specific implementation of the TES that would allow us to test the motif experi-
mentally. We chose parts for the device based on previous characterisation data. The input to our
design is a small molecule sensor that regulates the activity of a promoter and a THS is used
to regulate translation. The THS forms a hairpin secondary structure that encapsulates both
the RBS and start codon of our down stream gene of interest, preventing ribosomes binding to
and translating the gene. Translation is activated when a separately transcribed sRNA binds
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to the THS. This exposes the RBS and start codon, enabling ribosomes to translate the gene.
Translation of a protein regulated by a THS is activated by increasing the concentration of
separately transcribed sRNA. We used a second genetic sensor to regulate the rate of sRNA tran-
scription. The TES was used to regulate production of a yellow fluorescent protein (YFP), allowing
us to characterise the rate that our device produced protein in single cells by measuring their
fluorescence. Our device was assembled as a single plasmid, with which cells were transformed
to test the device.
We used a THS to regulate the rate of translation of our gene of interest for several reasons.
Firstly, THSs have been shown to strongly repress translation; there is a large fold change
between the amount of gene expressed when sRNA is present to activate translation, and when
sRNA is absent and translation is repressed. Secondly, 26 THSs have been built to date and shown
to regulate different genes within the same circuits. Out of all THSs, when sRNA was transcribed
along side a non-cognate THS, translation was only activated to 12 % of its maximum rate [55].
This shows that multiple THSs could be used within the same circuit without interfering with
each other. In addition to these 26 devices, a large number of novel THS designs are possible,
more so than other synthetic riboregulators. This is because the THS sequence is not limited by
the need to include the start codon or Shine-Dalgarno region in their sequence, as is the case
with both natural and synthetic riboregulators [16, 17, 55, 68, 98]. By using THSs as a second
mode of gene regulation in a TES, if multiple TESs need to be used in the same circuit, new
TES designs would not be limited by the availability of new THSs. Finally, THSs could activate
translation in response to mRNAs native to a host strain, allowing us to regulate rates of protein
production in response to dynamic cellular processes happening in a host, like metabolism or
growth. This would make it possible to incorporate the TES into novel circuits that can tune and
fix themselves, making them robust to changes in their host’s behavior that happen in response to
changes in their environment. These properties make THSs perfect for tuning protein production
in our TES design, as they would allow us to use many in larger circuits and build versatile
circuits applicable to real world conditions.
Whilst a host’s native mRNA could have been used to dynamically tune protein production,
we used a genetic sensor to produce the synthetic sRNA that activates a THS system (THS)
that had already been characterised [55]. We used promoter Ptac to regulate the rate of tran-
scription of the translation activating sRNAs. The activity of Ptac increases in response to an
increase in concentration of small molecule isopropyl β-D-1-thiogalactopyranoside (IPTG). To
halt transcription of sRNA we used the terminator L3S3P11 after the sRNA [32] (Figure 4.3).
The region of the circuit encoding the sRNA is immediately followed on our circuit plasmid by
a region of DNA encoding our gene of interest regulated by a toehold switch that is activated by
the upstream sRNA. The activity of promoter Ptet was used to regulate the rate of transcription
of the THS and downstream YFP. The activity of Ptet increases in response to small molecule
anhydrotetracycline (aTc).
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Figure 4.3: Design of a tuneable expression system (TES) (A) Sensors regulate rates of transcription
(TX) and translation (TL) to control the output from the TES (top). The input regulates transcription of a
yellow fluorescent protein (YFP), an upstream toehold switch (THS design 20) [55] renders the transcript
inactive to translation until it binds to small RNA 20 (sRNA20) and is made active (bottom). T1 and T2
represent transcriptional terminators L3S3P11 and L3S2P21. (B) Schematic of toehold switch (THS)
implementation. Regions on the THS RNA marked a and b (top) hybridize with their reverse compliments
on the trigger RNA (bottom) marked a* and b*, respectively (adapted from [55]).
Genes are transcribed from a transcription start site, which is upstream of a gene’s translation
start codon (AUG). Only mRNA downstream of the start codon is translated, meaning there is
a region of transcribed RNA at the 5’-end of an mRNA transcript that is not translated. This
region, known as the 5’-untranslated region (5’-UTR), affects the rate of translation of a gene
[83]. Changing a promoter in a transcriptional unit changes the 5’ UTR which in turn affects
the rate of translation. To insulate our gene of interest from this effect and allow us to change
the promoter we used without seeing unpredictable effects on circuit function, we used a RiboJ
insulator [83]. RiboJ is a 70 nt sequence that consists of a hammerhead ribozyme at its 5’-end
and a hairpin at its 3’-end. Once transcribed, the hammerhead ribozyme cleaves itself, removing
the upstream 5’-UTR. Following the insulator, THS number 20 (THS-20) [55] regulates the rate
of translation of our gene of interest, YFP. Transcription of YFP is terminated by the L3S2P21
terminator [32] (Figure 4.3).
4.3.2 Modelling and simulation of a biological implementation
Before building the TES, we adapted our model found in Eqs.(4.10 – 4.13) to predict how the
TES might behave. We adapted the model so that it accounts for basal rates of transcription from
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the input and tuner sensors. So rM and rS become:
rM =α0M +αM (4.14)
and
rS =α0S +αS (4.15)
where α0M and α
0
S are the basal rates of transcription of mRNA and tuner sRNA and αM and
αS are the activities of the input and tuner promoters.
We derived biologically relevant parameters (Table 4.1) that we used to simulate the TESs
behaviour. We found that as the rate of mRNA transcription increased, there was a sigmoidal
increase in the number of proteins produced at steady state (Figure 4.4). As the rate of tuner
transcription increased, the rate of protein production increased at all input levels, transforming
the response function (Figure 4.4). The increase in the rate of protein production for an input
when the tuner promoter activity was increased was non-linear. There is an optimal range of
sRNA transcription rates for tuning the response function and shifting the sRNA transcription
rate outside of this range has little effect on the rate of protein production.
Within this optimal intermediate range of sRNA transcription rates, which is between 0.012–
7.65 RNAP min-1, increasing the rate of sRNA transcription over one interval (from 0.3 to 1.5
RNAP min-1) resulted in a 2.6-fold increase in protein production when the input was 1 RNAP
min-1 (Figure 4.4). This can be seen from Figure 4.4, where, within the intermediate range
of sRNA transcription rates, the same relative increase in sRNA transcription rate shifts the
response function upwards. Outside of this range, increasing the rate of sRNA transcription
has little effect on the rate of protein production. Below and above the intermediate range, an
equivalent relative increase in rate of sRNA transcription, from 0.0001 to 0.0124 RNAP min-1
below the range and from 7.65 to 190 RNAP min-1 above the range, yielded only 1.04–fold and
1.3–fold increases in the rate of protein production. This can be seen from Figure 4.4 where at
low and high rates of sRNA transcription, different rates of sRNA transcription yield overlapping
response functions that are almost identical.
4.4 In-vivo performance of a tuneable expression system
A genetic circuit implementing the TES was assembled as a plasmid (Figure 4.5) and E. coli
cells were transformed with this construct. We used flow cytometry to measure the fluorescence of
populations of these cells when they were in exponential growth, i.e. when protein production was
at steady state. To alter the rate of transcription and translation of YFP, populations of cells were
grown in different combinations of inducers aTc and IPTG. This was done for three biological
replicates. The median fluorescence of populations for each biological replicate was calculated and
the mean of these values was found. Next, to find the input and tuner input promoter activities
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Table 4.1: Parameters used to model tuneable expression systems
Name Description Value(s) Unit Ref.
αM Induced transcription rate
of input promoter
0 to 300a RNAP min-1 [124], [72], [61]
αS Induced transcription rate of tuner
sRNA promoter
0 to 190b RNAP min-1 [124], [72], [61]
α0M Basal transcription rate of input pro-
moter
0.0886c RNAP min-1 [124], [72], [61]
α0S Basal transcription rate of tuner sRNA
promoter
0.2307c RNAP min-1 [124], [72], [61]
βP Rate of protein production from active
toehold switch
5 Proteins complex-1 min-1 [105]
k+C Association rate of sRNA and mRNA
into complex
0.0257d complexes transcript-1 min-1 [137]
k−C Dissociation rate of complex into sRNA
and mRNA
0.00672d transcripts complex-1 min-1 [137]
γM Degradation rate of mRNA 0.231e min-1 [7]
γS Degradation rate of sRNA 0.231e min-1 [7]
γC Degradation rate of mRNA:sRNA com-
plex
0.231e min-1 [7]
γP Degradation rate of output protein 0.035f min-1 [81]
a. We assume the maximum rate of transcription initiation of Ptet is the same as a constitutively expressed
gene [72], and that a plasmid with a p15A origin of replication has 15 copies per cell [61].
b. The maximum transcription initiation rate of Ptet is 1.57 times higher than Ptac.
c. Maximum rates of transcription initiation of sensors, aM and aS , were divided by fold changes for Ptet
and Ptac as measured in previous work [124].
d. Assuming rates of RNA hybridization are similar to DNA hybridization [137].
e. We assume that the half-life of the THS transcript and tuner sRNA are similar to the average mRNA
half-life in a cell, measured to be 3 minutes in exponentially growing cells [7].
f. We assume dilution of proteins caused by cell growth is the main cause of degradation and cell doubling
time of 20 min.
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Figure 4.4: Modelled response function of tuneable expression system (TES). Response functions
show number of proteins at steady state found using our deterministic model of the TES, presented in Eqs.
(4.10 – 4.13), simulated at varying tuner inputs. Line colour indicates promoter activity of tuner inputs,















































Figure 4.5: Schematic diagram of tuneable expression system testing plasmid. Synthetic Biology
Open Language visual (SBOLv) glyphs are are used to demonstrate our plasmid design [87] KanR is
the kanamycin resistance gene, p15A is the origin or replication. tetR is t e coding sequence for the
tetracycline repressor protein, the transcription factor used in the Ptet sensor system. lacI is the coding
sequence for the lac inhibitor protein, the transcription factor used in the Ptac sensor system.
(outputs from Ptet and Ptac), relative to the concentrations of aTc and IPTG, the inputs to Ptet
and Ptac, respectively we characterised the sensors on their own.
53
CHAPTER 4. A TUNEABLE EXPRESSION SYSTEM
4.4.1 Characterising sensors to find inputs to the tuneable expression
system
To find the relationship between the input promoter activities and the inducer concentrations
that are the inputs to the sensors we transformed cells with circuit characterisation plasmids.
The plasmids each contained one of the sensors which was used to drive the expression of YFP. We
grew these cells in a range of inducer concentrations and measured their fluorescence using flow
cytometry. We found the response function for the sensors (Figure 4.6), which relates inducer
concentration to promoter activity in terms of cell fluorescence. We converted the sensor outputs
from cell fluorescence in arbitrary units (a.u.) into relative promoter units (RPU), a measure of
promoter activity calculated by dividing a fluorescence measurement by the fluorescence given
off by a standard genetic construct that constitutively expresses YFP (Chapter 3, Section 3.4.5)
[19, 100]. By converting the sensor outputs to RPUs, we can compare our device performance to
other devices [100]. Both promoters are leaky, that is, they’re active when no inducer is present.
In the absence of inducer, we see output promoter activities for Ptet and Ptac of 0.002 and 0.003
RPU, respectively. We also see a significant difference in the maximum outputs of each device,
with Ptet giving an output of 6.6 RPU, which is 2.4-times higher than Ptac (2.75 RPU).
4.4.2 Response to increased transcription rates
We characterised the TES over a range of different combinations of aTc and IPTG concentrations.
By varying concentrations of aTc and IPTG we changed the activity of promoters Ptet and Ptac,
respectively, which varied the rates of transcription of mRNA and sRNA. As we increased the
rate of mRNA transcription, we saw a sigmoidal increase in the amount of protein produced.
We see this for all tuner promoter activities we tested (Figure 4.7B). There was little increase
in output as the input was increased from 0.002 to 0.5 RPUs. As the input increased above 0.5
RPU, the amount of protein produced increased when the input promoter activity was increased
(Figure 4.7B). This is as we expected from our model (Figure 4.7A).
At rates of sRNA transcription less than 0.03 RPU, as we increased the rate of transcription
of mRNA, we saw a 14-fold increase in the rate of protein production (Figure 4.7). The THS we
used has been shown to almost fully repress translation of a gene until the sRNA is added [55], so
when rates of mRNA and sRNA transcription were lowest, we expected no protein to be produced.
However, we measured 25.6 a.u. of fluorescence. This could be due to: the THS not functioning
properly, leaky transcription from the tuner promoter Ptac causing sRNA to be produced which
unfolds the THS and activates YFP production, or a combination of these. At its lowest output
activity, the tuner promoter is still active at a level of 0.003 RPUs, suggesting that sRNA is still
being produced. This could explain why the output from the TES increases with an increase in
the rate of mRNA transcription when the tuner promoter activity is low.
Fold-change is a useful characteristic of a device’s performance [130]. We calculated the fold-
change of the TES for low and high outputs at all tuner inputs and found it decreased significantly
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Figure 4.6: Characterisation of sensors. (A) Design of sensor modules. An increase in the concentra-
tion of sensor input increases the rate of transcription of the sensor (top). aTc increases activity of input
promoter, Ptet, whilst IPTG increases activity of tuner promoter, Ptac (bottom). (B) Response function for
Ptet (C) Response function for Ptac.In both response functions, points are means for 3 biological replicates,
errorbars show ±1 standard deviation. Output promoter activities are given in relative promoter units
(RPU).
as we increased the tuner promoter activity (Figure 4.8A). Fold change dropped from 14.1 at
low tuner inputs (Ptac = 0.003 RPU), to 2.4 at high tuner inputs (Ptac = 2.61 RPU). Whilst the
fold-change decreased with an increase in tuner input, the absolute difference between the output
when the rate of mRNA transcription is highest and lowest, the dynamic range, increased from
53 at low tuner promoter activity (Ptac = 0.003 RPU) to 695 at high tuner promoter activity (
Ptac = 2.61 RPU) (Figure 4.8B). The fold change decreased despite an increase in dynamic range
because the the rate that protein was produced by the TES at the lowest input promoter activity
( ymin), increased significantly with an increase in the rate of sRNA transcription (Figure 4.8C).
The parts we used to build the TES define the maximum and minimum rate that the TES
can produce protein. Based on how the input promoter (Ptet), tuner promoter (Ptac) and THS
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behave individually, we expected to see higher fold changes in output. Assuming mRNA is only
produced due to Ptet activity, the number of active mRNAs able to be translated will be less than
the total number of mRNAs transcribed due to Ptet activity, because, due to the THS, only a
fraction of mRNA transcribed (those bound by sRNA) are translated. We assume that when the
tuner promoter activity is highest (Ptac = 2.61 RPU), at the lowest input promoter activity (Ptet
= 0.002 RPU), there is an excess of sRNA compared to mRNA, so the majority of mRNAs are
bound and can be translated. Under these inputs, the number of active mRNAs bound to sRNAs,
is similar to the number of mRNAs transcribed by Ptet at its lowest activity. This rate of protein
production, ymin′ , is the amount of active mRNA produced by the TES when the input promoter
activity is lowest (Ptet = 0.002 RPU), and the activity of the tuner promoter is highest, (Ptac =
2.61 RPU).
The highest rate that the TES can transcribe mRNAs is less than or equal to the highest
rate that RNA can be transcribed by the input promoter when it is most active (when Ptet =
6.6 RPU). mRNA is translated when it is bound to sRNA, so the number of mRNAs that are
active and can be translated is limited. This further limits the maximum rate that the TES
can produce protein. Assuming all sRNA molecules bind to and activate mRNAs, the number of
active mRNAs available to be translated is the same as the number of sRNAs produced when























Figure 4.7: Response of the tuneable expression system (TES) to changes in input and tuner
promoter activities. Experimental response function of the TES, points are the mean of three biological
replicates and error bars show standard deviation. Lines are fitted hill functions at different tuner inputs
(light–dark: 0.003, 0.03, 0.15, 0.43, 0.9, 2.6 RPU).
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Figure 4.8: Effect of tuner input on device performance. (A) Fold change of the TES against tuner
promoter activity. (B) Dynamic range against tuner promoter activity (C) Minimum protein production in
response function (ymin) against tuner promoter activity. Points are means calculated from three biological
replicates, error bars are ± 1 standard deviation.
at maximum rate, Y maxTES , when input and tuner promoters, Ptet and Ptac, are fully active and
their outputs are 6.6 RPU and 2.61 RPU, respectively. Under this configuration of inputs, the
number of mRNA molecules bound to sRNA that can be translated is the same as the number of
sRNA molecules that Ptac produces when it is most active. Assuming the sensors produce the
same amount of RNA in the TES as they did when they’re characterised independently, we can
estimate the fold change between outputs from the TES at lowest and highest input promoter
activities (corresponding to 0.002 RPU and 6.6 RPU, respectively) when the tuner input is most
active (Ptac = 2.61 RPU).
Under these conditions, we would estimate a fold-change of 1305. However, what we see from
an equivalent configuration of inputs to the TES is a fold-change of 2, four orders of magnitude
lower than we expect.
A TES will have a low fold-change if the rate it produces protein at is too high at low input
promoter activities or too low when the input promoter activity is high. The TES’s output when
the input promoter is most active (Ptet = 6.6 RPU), could be too low for several reasons. First,
the TES’s input and tuner promoters might not function in the TES in the same way as they did
when they were characterised independently. Ptet and Ptac might be less active when they’re used
in the TES than when they were characterised. There are a couple of key differences in how we
use the THS compared to the context in which it was originally used [55]. The first difference is
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that we regulate production of sRNA and THS using Ptac and Ptet. When the THS was originally
characterised, sRNA and THS were both regulated by PT7 promoters on separate plasmids. sRNA
was expressed from a higher copy number plasmid than mRNA, and so was produced in excess of
THS. Second, we use a RiboJ insulator upstream of the THS [124]. The RiboJ insulator folds into
a strong hairpin structure that could have interfered with the THS. If the folded THS structure
is altered around the toehold that the sRNA binds to, it could have reduced the rate that sRNA
bound to the THS. This would have in turn reduced the rate of translation, causing the device to
produce less protein when both sRNA and mRNA are transcribed at their highest rates.
There are several reasons that the output from the TES could be higher than expected when
the input promoter activity is low. Firstly, if the toehold switch does not fold correctly, less energy
would be required to unfold the structure and allow ribosomes to translate the mRNA. The rate
of translation would increase by a rate proportional to the number of unbound mRNAs causing
the number of proteins produced at all inputs to increase. Another explanation for the high
concentrations of protein produced is that the terminator after the sRNA is not efficient. If this
is the case, some of the RNAPs transcribing sRNA may read through the terminator and cause
transcription of the mRNA, even though the input promoter was inactive.
4.4.3 Single cell variability
Gene expression is governed by interactions between biochemical molecules, such as DNA, which
can have low copy numbers in cells. Because of this, small fluctuations in the copy number of a
molecule can have a significant impact on the total number of copies in a cell. The copy number
of molecules involved in gene expression (i.e. the number of DNAs, mRNAs, sRNAs and proteins)
varies significantly over time and between different cells, making gene expression a stochastic
process [41, 110].
As gene expression is stochastic, the concentrations of an expressed protein will vary in
individual cells growing in a population. For a genetic device to propagate a signal, its output
must change sufficiently when its input promoter activity switches. If a device’s input promoter
activity is low, but due to stochastic gene expression, a large percentage of cells harbouring the
device have outputs that suggest the input promoter activity is high, this will be problematic.
Based on average data for populations of cells harbouring the TES, when the tuner input
promoter activity is increased from low (0.003 RPU) to high (2.61 RPU), the fold-change of
the device decreased from 14 to 2.1. This suggests that, as the input promoter activity was
increased from low (0.002 RPU) to high (6.6 RPU) the amount of protein produced by cells in a
population varied significantly (Figure 4.7). However, when we looked at distributions that show
the concentration of protein in individual cells in a population, we saw that, the distributions
overlapped as input promoter activity was increased from 0.002 RPU to 6.6 RPU (Figure 4.9).
For a large percentage of cells it is difficult to determine, based on the amount of protein the TES
produces in the cell, if the device’s input promoter activity is low or high.
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Figure 4.9: Population wide performance of the tuneable expression system. (A) Distributions of
YFP fluorescence in populations of cells when the tuner promoter activity is low (bottom: 0.003 RPU) and
high (top: 2.61 RPU). Filled and black outlined distributions are for cells grown with low (0.002 RPU) and
higher (6.6 RPU) promoter activities, respectively. The autofluorescence distribution has a grey dotted line.
(B) Intersection between fluorescence distributions when input promoter activity if high and low. Points
are means calculated from three biological replicates, error bars are standard deviations.
We measured the overlap between population distributions when the input promoter activity
was high (6.6 RPU) and low (0.002 RPU) as a percentage. This measurement is the intersection
between distributions [126] and at all tuner input promoter activities we measured, it was high
(> 69%) (Figure 4.9B). Given two populations of cells harbouring the TES grown at high and low
inputs, it would be difficult to tell if any one individual cell from either population had an input
that was high or low.
4.5 Input promoter activities affect dynamics of protein
production
We wanted to see how changing the TES’s input and tuner promoter activities changed the rate
of protein production over time. The rate of protein production is related to the rate of cell growth
so we first determined whether growing cells in different inducer concentrations affected the
growth rate of cells harbouring the TES.
4.5.1 aTc and IPTG concentrations do not affect cell growth
To measure how the rate that the TES produces protein changes with time we grew cells
harbouring the TES in varying concentrations of aTc and IPTG. At regular intervals, a robotic
arm transferred the plate of cells to a plate reader that measured the optical density (OD600) and
fluorescence of populations of cells. Looking at the growth curves we generated, we see that the
two different biological replicates we tested do not grow in sync. For one of the replicates, there is
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Figure 4.10: Growth of cells containing a tuneable expression system. (A) Growth curves for
populations of cells harbouring the tuneable expression system (TES) grown in varying concentrations
of inducers aTc and IPTG. Cultures were inoculated with cells growing in stationary phase. We assume
that optical density (OD600) is proportional to cell density. All points denote OD600 for one of two biological
replicates. Growth curves at all inducer concentrations can be found in Figure A.1. Solid lines denote
growth curve fit to a mathematical model [35]. (B) Growth curve for cells harbouring a tuneable expression
system grown with no inducers, in media inoculated with cells growing in exponential phase. Points denote
OD600 for one of three biological replicates. Solid lines denote growth curve fit to a mathematical model
[35]
a lag of 200 minutes before cells start growing exponentially, for the other, cells start growing
exponentially at the start of growth (Figure 4.10A).
The growth of cells is not consistent across the two replicates. Growth curves for populations
of cells grown in the initial (steady state) set of experiments we ran, showed that across biological
replicates there was little variation in cell growth (Figure 4.10B). In these experiments, the
growth curves of all the replicates were well synchronized. The difference between these two
sets of experiments was that in the initial experiments, we inoculated media with cells that were
already in their exponential growth phase. In the dynamic experiments, media was inoculated
with cells in stationary phase (Figure 4.10A) (see: Chapter 3, Sections 3.4.3 and 3.4.1 for
cultures inoculated with cells growing in steady state and exponential phases, respectively).
When characterising circuits, to get reproducible results, media must be inoculated with cell
populations already growing at exponential phase. When media is inoculated with cells growing
in stationary phase, there could be a lag phase before cells start growing and as we show here,
this will happen in some populations and not others, so growth was inconsistent across biological
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Figure 4.11: Effect of inducer concentration on growth rate. Growth rate is the maximum gradient
of the curve that was fit to growth data (Figure 4.10).
replicates.
We fitted growth curves for populations of cells with a mathematical model (see: Chapter 3,
Materials and Methods, Section 3.4.8). We used numerical methods to find the steepest gradients
in the growth curves, which are the growth rates of the cell cultures. aTc and IPTG concentrations
did not affect growth rate, showing that using these inducers and sensor systems did not have a
toxic effect on cell growth (Figure 4.11).
We used a plate reader to measure the change in the average fluorescence of populations of
cells harbouring the TES, grown in combinations of aTc and IPTG concentrations, once every 16
minutes (Section 3.4.3). A particle swarm optimisation algorithm was used to fit our model to the
data (Chapter 3, Section 3.5.2) [71]. We related the input and tuner input promoter activities (αm









where: ymin and ymax are the minimum and maximum sensor outputs, respectively, n is the hill
coefficient, C is a scaling factor that relates fluorescence to RNAP flux and K is the concentration
of inducer that induces an output sensor activity to halfway between ymin and ymax. At higher
concentrations of aTc (0.63 and 4 ng/mL), the model fitted experimental data well. However, when
there was no aTc, the model failed to capture the TES’s behaviour (Figure 4.12). Parameters
from the optimisation can be found in Table 4.2. Looking at the experimental data there is
clearly a problem with how fluorescence was measured, as we do not capture any fluorescence
below around 100 a.u. (Figure 4.12). This is likely due to the sensitivity of the instrument we
used to measure fluorescence (Chapter 3, Section. 3.4.3), or the parameters used to set up the
instrument.
We plotted the time that fluorescence was detectable (i.e. over 100 a.u.), against aTc concen-
tration and IPTG concentration (Figure 4.13). Increasing the concentration of aTc decreased the
time taken for cells harbouring the TES to produce protein at a rate that made fluorescence in the
cells detectable. Increasing the concentration of IPTG further decreased the response time of the
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Table 4.2: Parameters fitted to experimental data
Name Description Value(s) Unit
ytetmin minimum promoter activity for input
promoter Ptet
1326 a.u.
ytetmax maximum promoter activity for input
promoter Ptet
7356 a.u.
ntet hill coefficient for input promoter Ptet 3.5 -
K tet Inducer concentration that promoter
activity for input promoter Ptet is
halfway between its minimum and
maximum
1.26 -
Ctet conversion factor for input promoter
Ptet
0.0063 RNAP a.u. −1 min−1
ytacmin minimum promoter activity for tuner
promoter Ptac
464 a.u.
ytacmax maximum promoter activity for tuner
promoter Ptac
7356 a.u.
ntac hill coefficient for tuner promoter Ptac 0.8 -
K tac Inducer concentration that promoter
activity for tuner promoter Ptac is
halfway between its minimum and
maximum
1.2 -
Ctac conversion factor for tuner promoter
Ptac
0.0038 RNAP a.u−1 min−1
βP Rate of protein production from active
toehold switch
0.51 proteins complex-1 min-1
k+C Association rate of sRNA and mRNA
into complex
1.33 complexes transcript-1 min-1
k−C Dissociation rate of complex into sRNA
and mRNA
0.0084 transcripts complex-1 min-1
γM Degradation rate of mRNA 0.075e min-1
γS Degradation rate of sRNA 0.446 min-1
γC Degradation rate of mRNA:sRNA com-
plex
0.22 e min-1
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Figure 4.12: Change in the rate protein production over time. Points are for single biological
replicates. They represent the average concentration of yellow fluorescent protein (YFP), in arbitrary
units (a.u) for a bulk of cells. Change in YFP concentration with time is shown for cells grown in varying
concentrations of aTc, which increases the input promoter activity and IPTG, which increases the tuner
promoter activity. Dashed black line shows the output from the model, Eq. (4.10 - 4.13), fit to the data.
Full data sets can be seen in Figure A.2.
device (Figure 4.13). At a low tuner promoter activity, associated with an IPTG concentration of
0 mM, increasing the input promoter activity from low to high (aTc concentrations from 0 to 4
ng/mL) made the response 4 times faster. At a high tuner promoter activity, associated with an
IPTG concentration of 1000 mM, the same change in input promoter activity results in a 175-fold
faster response time. As we expected, increasing the tuner promoter activity and input promoter
activity made the TES respond faster.
4.6 Discussion
In this chapter we presented a simple motif for gene regulation which we called a tuneable
expression system (TES). The TES uses a promoter as its input which regulates the rate of
transcription of a gene of interest. A second mode of gene regulation was used to tune the rate of
protein production for any given input. As a proof of concept, we designed a TES that uses toehold
switches (THS) to tune production of a yellow fluorescent protein (YFP). The input to the device is
the output from a sensor that we used to regulate the rate that YFP was transcribed in response
to the small molecule aTc. Upstream of the YFP, a toehold switch folds in a way that prevents
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Figure 4.13: Tuneable expression system produces protein at different rates at different in-
puts. The response time is the time taken for a population of cells harbouring the tuneable expression
system to produce an average fluorscence greater than 100 a.u.
ribosomes binding to it, repressing translation. The output from a second sensor increases the
rate that a small RNA (sRNA) is transcribed. The sRNA interacts with the THS upstream of YFP
to increase the rate that YFP is translated. We built a model that used parameters realistic to
the parts in our design and used it to predict how the proposed design might behave.
Next, we physically built and experimentally tested the TES and saw that increasing the rate
of sRNA transcription increased the amount of protein produced at all input promoter activities.
However, we noticed two issues in the device’s performance. First, the fold-change of the TES
was lower than we expected; it was 14 when tuner input was high (2.61 RPU) and 2 when it
was low (0.003 RPU). Second, for populations of cells containing the TES growing at low and
high input promoter activities, at least 69% of individual cells produced protein at the same rate.
The percentage of cells in a pair of distributions that produce protein at the same rate is the
intersection between the distributions.
We propose a number of reasons for the fold-change of the TES being lower than expected.
First, the THS might not have been folding properly, so ribosomes were able to bind to the RBS
and translate YFP. In this case, the protein production rate when the inputs were at a minimum
would be higher than expected, causing a low fold-change. Alternatively, the THS may form
too tight a structure in the conditions we use it in. This would mean that sRNA added to the
system doesn’t unfold the THS to expose the RBS to ribosomes, so the protein production rate
when both input promoter activities are at their highest would be lower than expected. The THS
might not have been folding correctly because the RiboJ insulator directly before the THS may
interfere with its folding. As is the case with THSs, how a RiboJ works is heavily determined
by the secondary structure of RNA that it folds into. It is possible that the RiboJ and THS each
interferes with how the other part folds and so affects the performance of their neighbour. If the
RiboJ is interfering with the performance of the THS, we can improve the fold-change of the




Similarly, we want to lower the intersection between two distributions of cells when the
input promoter activities are high and low. We can do this in one or more of three ways. First,
we can reduce the variation in the number of proteins produced per cell in populations of cells.
Second, we can increase the average amount of protein produced by cells when the input promoter
activity is high. Third, we can lower the average amount of protein produced by cells when the
input promoter activity is low. By increasing the rate of sRNA transcription, we can increase the
amount of protein produced in cells. This would decrease the intersection whilst also increasing
the amount of protein produced. In the design presented here, when the input promoter activity is
high, there is always a lower concentration of sRNA produced than mRNA because we produced
sRNA using a promoter that has a lower maximum activity than mRNA. We could increase the
fold-change of the device by increasing the maximum amount of sRNA that we produce and in
doing so, reduce the intersection between populations of cells grown with low and high input
promoter activities.
We characterised how the growth of cells harbouring the TES changes depending on input
and tuner promoter activities and found that there was no correlation between input and tuner
promoter activities and growth rate. We measured how the rate of protein production in cells
harbouring the TES changed with time. We used this data to fit our mathematical model using
a particle swarm optimization algorithm [71]. We found that at high input and tuner promoter
activities, the fitted parameters matched well with experimental data, however, the modelled
responses do not match experimental data at low input and tuner promoter activities. As with the
growth data, the time course data for protein production (i.e. fluorescence) that we used to fit the
model was only made up from two biological replicates. The fitted parameters might fit the data
better if more repeat experiments were carried out. We looked at how long it took for populations
of cells harbouring the TES to produce enough fluorescent protein for us to detect when the
cells were grown in different inducer concentrations. We found that as we increased the input
promoter activity by increasing the concentration of aTc, the cells harbouring the TES produced
protein faster. When we increase the tuner promoter activity by increasing the concentration of
IPTG that cells were grown in, cells produced protein even faster.
The results in this chapter suggest that the TES’s performance is limited by two features
of its design. First, when characterised alone, the maximum rate that RNA was transcribed by
the input promoter (Ptet) was more than double that of the tuner promoter (Ptac). This suggests
that when both promoters were at their most active a lower concentration of sRNA relative to
mRNA was produced, resulting in only a fraction of transcribed mRNAs being activated and
translated. This would limit the maximum output of the device. Second, the THS we use to
regulate translation of the output protein might not be folding correctly due to the adjacent RiboJ
insulator. This might have prevented it from sufficiently repressing translation or being activated
by sRNAs. If this is the case, we can optimize the TES’s performance by boosting the rate of
sRNA transcription and removing the RiboJ insulator.
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In the following chapter we use a combination of deterministic and stochastic modelling to
test if increasing the rate of sRNA transcription will improve device performance. We then use
thermodynamic modelling to investigate the effect that the RiboJ insulator has on the THS.
Results from modelling are used to inform the design and construction of new TES variants
which we then validate experimentally.
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Model Guided Optimization of
Tuneable Expression System
5.1 Introduction
In the last chapter we built and tested a device called a tuneable expression system (TES) that
allows us to tune the rates of transcription and translation of a gene of interest. The device’s
input is the rate that it transcribes a gene, its output is the rate that it produces protein. The
relationship between the two is tuned by controlling the rate the gene is translated, but doing
so came at a cost. As we tuned the device the fold-change between its on and off output states
significantly decreased, from 14 at low to 2.4 at high rates of translation. We also found that, for
two populations of cells grown at high and low inputs, a high number of individual cells in one
population produced the same amount of YFP as cells in the other. Under all the conditions we
tested, the fraction of the populations that overlapped, the intersection between distributions,
was greater than 69%. Based on the these findings, we suggested two causes of these problems.
Firstly, if the maximum amount of protein the TES produces is low, the fold-change of the
device will be low. The TES might not produce enough sRNA to enable all the mRNAs we
transcribe to be translated, so the amount of protein the TES produces is lower than it could
be. This could have caused the device’s fold-change to be low. Secondly, we used a self-cleaving
ribozyme, RiboJ, to insulate the expression of our gene of interest from the contextual effects
caused by its upstream promoter. Once transcribed, the RiboJ insulator folds and self-cleaves,
leaving a strong hairpin [34]; this hairpin structure might interfere with the speed that the THS
folds and the stability of its final structure. This in turn may have affected the rate of protein
production.
In this chapter we use mathematical and biophysical models to optimize the devices design.
We then implement and test these improvements in-vivo. Through this process we reveal the
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causes of the previous performance issues and find novel insights that synthetic biologists can
use to build better genetic circuits using RNA–based control elements.
5.2 Design improvements
When the original THS was first developed [55], the THS and sRNA were transcribed using the
same promoter but on separate low and high copy number plasmids, respectively. This ensured
that the sRNA’s production rate was higher than the THS’s. The excess of sRNA this produced
resulted in most of the THS molecules being bound to sRNAs, enabling them to be translated.
In our original TES design, the sRNA and THS were expressed from the same plasmid. sRNA
transcription was regulated by Ptac and transcription of the THS was regulated by Ptet. When we
characterised the promoters independently the maximum activity of Ptet was more than double
that of Ptac. We hypothesised that when both promoters were at their highest activities there
was an excess of THSs over sRNAs which limited the achievable rate of translation.
To increase the maximum rate of protein production from the TES and potentially improve
the fold-change of the device, we could increase the rate that sRNA is transcribed at. The increase
this will cause in amount of protein produced by the TES could also decrease the intersection
between population distributions for on and off states. Another way we could reduce intersection
would be to reduce the variation in the amount of protein produced by cells in a population.
Gene expression in cells is a stochastic process, so we expect to see variation in the amount of
protein that individual cells produce across a population of bacteria. Biochemical processes tend
to be more stochastic when they involve molecules that occur in low numbers. As the number
of molecules of a species gets closer to zero, small fluctuations have a significant impact on the
total number of molecules present. RNAs are a good example of this, they degrade fast relative to
other molecular species, such as proteins, so the number of RNAs tends to be low, making RNAs
a major source of noise in gene expression [5]. If the number of all RNAs in a cell is increased,
we would expect to see less variation in gene expression, which would lead to less variation in
protein production.
The toehold switch sequence is made up of 3 Gs, a 12 nt linear "toehold" and then a 47 nt
sequence that, when at equilibrium, forms a hairpin structure containing the 8 nt RBS inside
a loop [55]. For the hairpin loop to occlude the ribosome, it needs to have a strong and stable
secondary structure, so the hairpin has a low, negative free energy. The more negative the free
energy of an RNA secondary structure, the harder it is to unfold because more energy is required
to do so. For the sRNA to unfold the hairpin structure, the toehold region of the switch must
be linear and unbound. When sRNA binds to the THS, initially, the first 12 nt of the sRNA
binds easily to the linear toehold because it does not need to unfold the strong hairpin secondary
structure. This initial binding to the toehold triggers a branch migration process, where a series
of small intermolecular interactions unfolds the hairpin to reveal the RBS. Less energy is needed
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to unravel the hairpin loop once the sRNA has already bound the toehold. Although the hairpin
of the THS is stable, the toehold makes it energetically favourable for the sRNA to bind to it and
trigger its unfolding.
We hypothesized that the RiboJ insulator upstream of the THS might interfere with the
toehold, making it easier or harder for the sRNA to unfold the THS, which either increases or
decreases the rate that the sRNA can bind. The speed that the hairpin folds also affects how well
the THS represses translation. Based on simulations of bases pairing when RNA folds around an
RBS to prevent translation, it was shown that RNA structures can have similar free energies and
still fold and occlude ribosomes at different speeds, which affects the rate of protein production
[43]. This effect can cause over 1000-fold variation in the rate of protein production. If the time
taken for the switch to fold and prevent ribosomes binding the RBS is more than the time taken
for a ribosome to bind to an RNA and initiate translation, then the probability of a ribosome
successfully binding to an RBS and initiating translation is greater. If the RiboJ slows the rate of
THS folding, the THS will not effectively stop ribosomes translating our gene of interest, so the
rate of translation will be higher, even when no sRNAs are present [43]. Therefore, we propose
that removing the RiboJ insulator would improve the TES’s performance.
5.3 Increasing sRNA concentration
When the input and tuner promoters are most active, the concentration of the sRNA is expected
to be less than half the concentration of the THS. Less than half of the THS molecules are bound
by sRNAs and so less than half of the mRNAs can be translated. We wanted to increase the
number of sRNAs that the TES can produce, so at high input and tuner promoter activities, there
will be more sRNAs to bind to THSs which will enable more protein to be produced. We hoped
this would increase the fold-change of the TES.
5.3.1 Modelling increased rate of sRNA transcription
To test our theory, we used the model derived in Chapter 4 to simulate how changing the input
and tuner promoter activities and sRNA and mRNA association rates affected the fold change of
the TES (Figure 5.1). All simulations were run with the model shown in Eqs. (4.10 - 4.13) with
parameters shown in Table 4.1. Input promoter activity was simulated at rates that increased
in logarithmic intervals from 0.0001 RNAP to 300 RNAP min−1. Increasing the rate of sRNA
transcription increased the TES’s fold-change (Figure 5.1A). We see this trend at all rates
of RNA association we tested. However, when the tuner promoter activity is low (<1 RNAP
min−1), increasing the tuner promoter activity doesn’t affect the device’s fold change (Figure
5.1B). When the tuner promoter activity increases above a certain point (>1 RNAP min−1), the
fold-change of the device increases significantly. This trend is seen at all rates of RNA association.
As we increase the rate of RNA association, the increase in tuner promoter activity needed to
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increase the fold-change of the device decreases. This shows that if we increase the rate of sRNA
transcription enough, we should be able to increase the fold-change of the device.
Another problem with the performance of the THS was that a large percentage of individual
cells from populations of cells grown at low and high input promoter activities showed similar
fluorescence levels. The intersection between these two population distributions was more than
69% at all rates of sRNA transcription we tested (Figure 4.9B). We wanted to decrease the
intersection between distributions by increasing the distance between them. We predicted that if
we increase the rate of transcription of sRNA to increase the device’s fold-change we will also
decrease the intersection.
































































Figure 5.1: Simulations show how changing model parameters changes molecule concentra-
tions. The rate of association between sRNA and mRNA was simulated at, from left to right panels,
0.0257, 0.257 and 2.57 complexes transcript−1 min−1. (A) Top panel shows concentration of protein at
steady state vs input promoter activity (input). Bottom panel shows changes in the ratio between mRNA
and sRNA concentrations at steady state (mRNA/sRNA) vs. Input. (B) Changes in fold-change between
low and high inputs with tuner promoter activity (tuner). Ranges of tuner promoter activity are shown in
coloured bands where colour signifies intervals between: 0.0001, 0.0005, 0.0024, 0.012, 0.056, 0.27, 1.3, 6.4,
31, 150 and 730 RNAP −1, from light to dark.
To test if increasing the rate of transcription of sRNA would decrease the intersection between
two population distributions, we ran stochastic simulations of our model found in Eqs. (4.10
- 4.13) (see Chapter 3, Section 3.5). We ran simulations at both low and high rates of sRNA
transcription and found that increasing the rate of transcription of sRNA increased the distance
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Figure 5.2: Population distributions from stochastic simulations of a tuneable expression sys-
tem. 5000 stochastic simulations were run for the TES at low (1 RNAP min−1) and high (1.5 RNAP min−1)
promoter activities, shown by grey and black outlined distributions respectively. This was repeated at low
(1.5 RNAP min−1) and high (5 RNAP min−1) tuner promoter activities, shown on the top and bottom of the
figure, respectively.
between the two population distributions as well as decreasing their variation (Figure 5.2).
These effects reduced the intersection from 31% at low rates of sRNA transcription to 6% at high
rate of sRNA transcription.
5.3.2 Design of a booster plasmid to increase sRNA transcription rate
To increase the rate that sRNA was transcribed we designed a sRNA booster plasmid. Cells were
cotransformed with the TES and booster plasmids (Figure 5.3). The booster plasmid produces
high levels of sRNA in response to IPTG. When cells harbouring the booster and TES are used
together, the booster design ensures that more sRNA is produced than mRNA, ensuring maximal
mRNA translation rates are achieved.
Two key features of the booster plasmid design ensure that high concentrations of sRNA are
produced. First, we placed transcription of sRNA under the control of a strong PT7 promoter
(Figure 5.4). PT7 promoters are transcribed by the viral T7 RNA polymerase (RNAP), which
processes DNA 8–times faster than the native bacterial RNAP [89]. In the genome of our testing
strain, E. coli BL21 Star (DE3), LacI represses transcription from a constitutive PLacUV5 promoter,
preventing the transcription of the downstream gene coding for T7 RNAP. When IPTG is added
to the system, it binds to LacI, changing its conformation in a way that prevents it repressing
transcription and thus enabling the downstream T7 RNAP gene to be expressed and allowing it to
transcribe the sRNA regulated by the PT7 promoter. Secondly, the booster plasmid was built with
a pColE1 origin of replication, which has a copy number of 50-70 copies per cell [85] (Figure 5.4).
This is 3–4.5 times higher than the ~15 copies per cell of the p15A origin used for the plasmid
containing the TES device. Because we have more copies of the booster plasmid, we expect that
the rate of transcription of sRNA will be higher than from the device plasmid (Figure 5.3).
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5.3.3 Increased sRNA concentration improves system performance
We characterised the TES in cells cotransformed with the sRNA booster plasmid. Compared to the
TES on its own, we saw an increase in protein production at higher rates of mRNA transcription
(> 6.04 RPU). Unexpectedly, the rate of protein production at low rates of mRNA transcription
(<0.5 RPU) decreased (Figure 5.5A). The most likely cause for this is that the sRNA booster
expresses a second antibiotic selection gene, ampR, which give cells harbouring the booster
resistance to the antibiotic ampicillin. The presence of a second antibiotic in the growth media,
and the added burden of expressing an additional protein will yield reduced rates of protein
production in the cells [9, 26, 27].
We calculated the fold-change for the device with the booster and found that at low tuner input
(0.002RPU), fold-change increased from 14 to 227. This is a large increase, however, fold–change
is still an order of magnitude lower than we expect based on how the sensor inputs to the device
were characterised independently, where we saw a fold-change of over 1000 (Chapter 4, Section
4.4.1). Whilst fold–change increased at all tuner inputs, the biggest increase was seen at the
lowest tuner input (a 16–fold increase at 0.003 RPU). Fold change increased by ~5–fold for tuner
inputs between 0.03–0.9 RPU and ~2-fold at a tuner input of 2.61 RPU (Figure5.5B).
5.3.4 Effect of increased sRNA concentration on output distributions
When we compare population distributions of devices characterized with the booster plasmid
against devices characterised without, the intersection decreases at all tuner inputs. The biggest
improvement was at a tuner input of 0.9 RPU, when the intersection dropped by 77%. The smallest
improvement was when the tuner input was 0.03 RPU and the intersection dropped by 25%.
At all other tuner inputs, the intersection dropped by >40% (Figure 5.5C). The improvements
are seen partly because the median output fluorescence at low inputs (0.002 RPU) decreases,
reducing the intersection between distributions. For example, at low input and high tuner input
promoter activities, the average median fluorescence in populations of cells with the booster













































Figure 5.3: Design of sRNA booster. PT7 is the T7RNAP activated promoter and TT7 is its terminator.
ampR is the gene encoding ampicillin resistance.
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Figure 5.4: Design of sRNA booster T7 RNA polymerase (T7RNAP) is encoded on the hosts genomes,
it transcribes sRNA from DNA found on a separate plasmid in response to IPTG.
median fluorescence at high input promoter activity (6.6 RPU) increasing. When input and tuner
promoter activity were high (6.6 and 2.61 RPU, respectively) the median fluorescence was 1.6
times higher with the booster, which further separated distributions and reduced intersection.
These changes can be seen from the response functions in Figure 5.5A, where the minimum
output decreases and the maximum output increases for all tuner promoter activities.
Our model was useful for improving the design of the TES, however, if we compare modelling
results to experimental results, we see that the model fails to capture key features of our
experimental system. For example, our model suggests that as we increase the rate of sRNA
transcription the fold-change of the device will remain the same or increase. Contrary to what
our model suggests, in our experimental system the fold-change decreases as we increase the
rate of sRNA transcription. The model fails to capture how tuning the rate of sRNA transcription
varies protein production to different extents at low and high input promoter activities. This
difference in behaviour suggests that we’ve failed to model key biological processes occurring in
the TES or that the parameters we use are incorrect. However, as we suggest previously, if the
THS is not working correctly in the TES, the TES would not behave as we expect based on model
predictions.
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Figure 5.5: Comparison of tuneable expression system performance with and without sRNA
booster plasmid. (A) Experimental response function for the TES. Lines show fitted hill functions for
tuner promoter activities 0.003, 0.03, 0.15, 0.43, 0.9 and 2.61 RPU, colored from light to dark red. (B)
Change in fold-change of device with change in tuner promoter activity. (C) Change in the fraction of
intersection of fluorescence distributions between cells grown at high (6.6 RPU) and low (0.002 RPU) input
promoter activities. For all plots, points are averages of three biological replicates, error bars show ± 1
standard deviation.
5.4 Removal of RiboJ insulator
5.4.1 Thermodynamic modelling
At low rates of sRNA transcription and high rates of mRNA transcription, the majority of THSs
will not be sRNA bound and should remain folded around their RBSs, preventing translation of
YFP. Therefore, at low rates of sRNA transcription we expect to see almost no protein production.
However, experiments showed fairly high rates of protein production even when sRNA was
produced at its lowest rates (Figure 5.5). This suggests that the THS was not folding correctly
and so failed to block ribosomes. We suggested in Chapter 4 that the RiboJ insulator might
interfere with toehold switch folding. Like the THS, the way in which RiboJ folds determines how
it functions. The strong RNA secondary structure that the RiboJ forms could prevent the THS
folding correctly, allowing YFP to be translated when it should have been repressed.
To test if the RiboJ secondary structure interferes with the THS, we modelled how pairing
between bases in the THS causes it to fold at equilibrium [45]. We did this for the THS with and
without cleaved upstream RiboJ insulators (for detailed method see: Chapter 3, Section 3.5.3).
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We then modelled RNA folding with the sRNA present (Figure 5.6). We found that the THS
structure was less stable with the RiboJ insulator upstream; the free energy of the THS was
-40.5 kcal/mol with the RiboJ compared to -65 kcal/mol. The less stable the THS structure the
easier it is for ribosomes to access the RBS. So, when the rate of sRNA transcription is low and
the THS is folded, the rate of translation of genes regulated by a THS next to a RiboJ will be
higher than for non-insulated genes. From our equilibrium base-pair model we see that the first
4 nts of the toehold section of the THS pairs to the RiboJ and are incorporated into a hairpin
structure (Figure 5.6). The toehold makes it easier for sRNA to bind to and unfold the THS. As
the first four nts of the toehold are incorporated into the RiboJ hairpin, more energy is needed for
the sRNA to bind to the toehold, initiate the unfolding of the THS and activate translation. As a
result, the sRNA will associate with the THS at a lower rate, leading to lower rates of translation.
The base-pair modelling approach we used predicts how bases will pair in RNA systems when
they are in equilibrium, however they fail to explain how non-equilibrium processes, such as
RNA folding, will affect our system. To address this, we modelled the time taken for a THS to
fold and compared it to the time taken for a THS with an upstream cleaved RiboJ to fold (for
method see: Chapter 3, Section 3.5.3). The kinetic model implements Monte Carlo procedures
to simulate stochastic folding of RNA sequences [45]. We found that it took 7-times longer for a









Figure 5.6: Predicted pairing of bases in the tuneable expression system at equilibrium. Sec-
ondary structure for insulated and non-insulated tuneable expression systems (TES) shown on the left and
right, respectively. Bottom figures show closed, inactive toehold switches (THS), top figures show active
THSs bonded with sRNAs. The red circle highlights the 4 nts of the toehold portion of the THS that are
bonded to RiboJ.
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Figure 5.7: Tuneable expression system plasmid map without RiboJ insulator. Schematic dia-
gram of the tuneable expression system plasmid without a RiboJ insulator (pVB003) in between Ptet and
THS20.
takes longer to fold, there is more time for ribosomes to initiate translation of downstream genes
before the THS blocks translation, so the rate of protein production will be higher. When sRNA is
not transcribed, we expect protein production to be repressed. These results could explain why
the TES with the RiboJ still produces protein when the rate of sRNA transcription is at its lowest
(0.002 RPU). Based on the findings from kinetic modelling and base-pair equilibrium modelling,
if we remove the RiboJ from our original TES design, we expect to see less protein produced at
low input promoter activities and more at high input and tuner promoter activities.
5.4.2 Removing RiboJ insulator improves performance
We wanted to see if the insulator was causing protein to be produced faster when the rate of
sRNA transcription was low and slower when the rates of mRNA and sRNA transcription were
high, so we removed the RiboJ insulator from the original TES design and tested the new variant.
Compared to the original design, the output from the device when the input promoter activity
was low (0.002 RPU), at all rates of sRNA transcription we tested, was lower (Figure 5.8A).
This supports the hypothesis that RiboJ interferes with how the toehold switch performs by
preventing it from sufficiently repressing translation of the associated gene.
As well as a decrease in protein production at low inputs, as we expected, we also saw an
increase in protein production when the input was at its highest (6.6 RPU). This likely happens, as
our model suggests, because the RiboJ binds to the toehold and slows down the rate of association
between sRNA and toehold switch. By removing the RiboJ, we increased this rate of association,
and in doing so, increase the rate of protein production (Figure 5.8A). These changes caused
the fold change of the TES to increase across all rates of sRNA transcription tested (Figure
5.8B). Compared to the original device, the dynamic range more than doubled, the fold-change
increased more than 10-fold at all rates of sRNA transcription and the fraction of intersection
between YFP distributions decreased by more than 50% (Figure 5.8).
Next, we wanted to see if we could further improve the device’s performance by using the
sRNA booster in combination with the non-insulated TES variant. We cotransformed the non-
insulated TES into cells with the booster plasmid and characterised their function. Compared to
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Figure 5.8: Comparison of tuneable expression system performances. (A) Lines show fitted hill
functions for tuner promoter activities 0.002, 0.03, 0.15, 0.43, 0.9 and 2.61 RPU, colored from light to dark
red. (B) Change in fold-change of device with change in tuner promoter activity (tuner). (C) Change in
fraction of intersection of fluorescence population distributions between cells grown at high (6.6 RPU) and
low (0.002 RPU) input promoter activities, with a change in tuner promoter activity. In all figures, points
are averages of three biological replicates, error bars show ± 1 standard deviation.
the non-insulated design the dynamic range did not improve. At low input promoter activities
it increased by 75%, but at high input promoter activities it decreased by 26%. In contrast, the
fold-change increased more than 2-fold at all tuner promoter activities (Figure 5.8B).
As we saw when we added the booster plasmid to the insulated TES, the rate of protein
production decreased at low input promoter activities across all tuner promoter activities. This
decrease in protein production caused the increase in fold-change, as there was no significant
increase in protein production at high inputs. At tuner inputs less than 0.03 RPU and at the lowest
input promoter activity (0.002 RPU), protein production is almost the same as autofluorescence,
showing that the THS tightly represses translation. However, at the lowest input promoter
activity we still see a significant increase in protein production as we increase the tuner promoter
activity.
At the lowest input promoter activity, we expected to see a small amount of mRNA transcribed
due to the promoter leaking. If this was the case, an increase in tuner promoter activity would
cause a small increase in the rate of protein production. What we see is a large increase in
protein production as we increase tuner promoter activity from low to high at low input promoter
activities. Increasing the tuner promoter activity from low to high (0.003–2.61 RPU) increases
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Table 5.1: Summary of tuneable device performances
Dynamic rangea,b(a.u.) Fold-changea,c(a.u.) Intersectiona,d
Design Lowe High f Lowe High f Lowe High f
Original 333 ± 53 877 ± 695 14 ± 1.7 2.4 ± 1.2 0.78 ± 0.06 0.69 ± 0.16
sRNA boosterg 538 ± 51 2064 ± 1070 227 ± 297 5.7 ± 1.8 0.46 ± 0.04 0.35 ± 0.15
Non-insulatedh 882 ± 134 2149 ± 409 445 ± 412 31 ± 16 0.26 ± 0.07 0.27 ± 0.06
Combinedi 1550 ± 209 1712 ± 584 1236 ± 613 66 ± 54 0.15 ± 0.04 0.22 ± 0.04
a. Average of median values from flow cytometry are ± 1 standard deviation calculated from three biological
replicates.
b. Dynamic range is the absolute difference in YFP fluorescence between low and high inputs (0.002 and
6.6 RPU).
c. Fold-change in YFP fluorescence (corrected for cell autofluorescence) for low and high inputs (0.002 and
6.6 RPU).
d. Fraction of intersection between flow cytometry YFP fluorescence distributions for low and high inputs
(0.002 and 6.6 RPU) (3).
e. Performance measured for a low tuner input (expected Ptac activity = 0.002 RPU).
f. Performance measured for a low tuner input (expected Ptac activity = 2.61 RPU).
g. Original designs (Figure 5.8) with the sRNA booster system (Figure 5.4).
h. Design without RiboJ insulator.
i. Design without RiboJ insulator but with sRNA booster (Figure 5.4).
the output when the input promoter activity is lowest (0.002 RPU) by >28–fold for all of the
TES variants. One explanation is that, when sRNA is transcribed the terminator after the sRNA
sequence fails to stop RNAPs from transcribing. The RNAP reads through the terminator and
transcribes the downstream THS and mRNA. As we increase the sRNA promoter activity, we
increase the rate of sRNA transcription and also the rate of mRNA transcription. This would
cause a significant increase in protein production at low mRNA promoter activities as we increase
the sRNA promoter activity, as seen in our results (Figure 5.8A). Moreover, the intersection
further decreased when we characterised the non-insulated TES with the booster (Figure 5.8C).
A summary of all device performances can be seen in Table 5.1.
5.5 Discussion
In this chapter we used a deterministic model of the TES to explore how changing key design
parameters affected its performance. This revealed that increasing the rate of sRNA transcription
increased the fold-change of the TES. We then used stochastic modelling to show that increasing
the rate of sRNA transcription decreases the fraction of intersection between distributions of
output proteins in cells grown at low and high rates of mRNA transcription. To increase the rate
of transcription of sRNA we built an sRNA booster plasmid which we used, alongside the TES
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plasmid, to cotransform cells. As expected from our model, the TES with the booster produced
proteins at a higher rate leading to a higher fold-change at all tuner promoter activities tested.
Next, we used thermodynamic models to simulate how the RiboJ insulator affects toehold
switch function. Our model suggested that positioning a RiboJ RNA upstream of a toehold switch
makes it less thermodynamically stable, preventing it from repressing translation as effectively.
A kinetic model of RNA folding for the THS with and without an upstream RiboJ showed that the
insulated THS takes 7-times longer to fold, meaning more ribosomes could translate a regulated
gene before the THS represses translation. The thermodynamic models we used effectively
predict RNA secondary structure for RNA strands in-vitro. However, due to the vastly different
conditions RNAs are exposed to in a cell, model outputs aren’t necessarily accurate at predicting
RNA secondary structure in-vivo [39, 78]. Despite this, we expected removing the insulator would
enable the THS to fold correctly and inhibit translation, so a non-insulated TES would produce
protein at a lower rate at low input promoter activities.
We built a TES variant without a RiboJ and found it produced protein at a higher rate at
high input promoter activities and a low rate at low input promoter activities, yielding a device
with a higher fold-change. Whilst this supports our modelling results, another explanation for
the high rate of protein production we were seeing at low input promoter activity, is that the
abundance of RiboJ insulated mRNA is around two-fold higher than non-insulated mRNA [34].
It is thought that the terminal hairpin formed by the cleaved RiboJ, stabilizes mRNA, increasing
its concentration and, therefore, the rate of protein production [22, 34, 83]. Whilst it is likely
that the RiboJ interfered with TES function through the mechanisms our model highlighted, the
RiboJ may have affected device performance in other ways. This has taught us that in general, if
building a device with two or more neighbouring parts that rely on the secondary structure of
their RNA to function, it is likely that the parts will interfere with each-other.
Finally, we tested the non-insulated TES with the booster plasmid. Compared with previous
variants of the device, the new TES variant showed higher fold-changes and lower intersection
for all tuner promoter activities tested (Figure 5.8). However, the rate of protein production still
increased with tuner promoter activity. An explanation for this is that when the tuner promoter
was active, the terminator after the sRNA sequence failed to terminate transcription. If this was
the case, RNAP would have read through the terminator and transcribed the THS and mRNA
in addition to the sRNA. Even when input promoter activity was at its lowest, mRNA would
have been produced at higher rates as we increased the rate of sRNA transcription. This is what
we saw from our experimental data. To verify if the increase in protein production happens due
to transcriptional read-through, we could sequence the RNA in cells grown at the lowest input
promoter activity and at varying tuner promoter activities [51]. If we see an increase in mRNA
production as we increase tuner promoter activity this would confirm that we get transcriptional
read-through. We could solve the problem of transcriptional read-through in one of two ways.
First, we could remove the sRNA cassette from the TES plasmid and express it solely from the
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booster plasmid. Second, we could rebuild the TES device plasmid, but with the sRNA cassette in
the reverse direction.
Based on these experiences, we recommend using thermodynamic modelling when designing
any device or circuits that use RNA based parts. These models are easy to use and have been
shown to be accurate [45]. Using them at the design stage could save resources wasted on re-
building and testing devices that fail due to RNA based parts behaving unexpectedly. In terms of
the work we present here, if we wanted to design a new TES that incorporates a RiboJ insulator
without affecting THS function, we could design a number of spacers that we could place between
the RiboJ and THS. We could use our thermodynamic modelling approach to find the best spacer
design before building and testing it.
The new TES variants performed significantly better than the original design. Their improved
performance makes them more suitable for use in larger genetic circuits. Instead of going through
design-build-test cycles, synthetic biologists could incorporate TESs into their original designs.
This way, if a circuit breaks, we could use the TES to tune devices and find the optimal rates of
gene expression for different genes in a circuit. Sensitivity analysis and optimization methods
could be used to identify parameters for the system that would yield a functioning circuit [44, 103].
However, such an approach assumes that the TES is modular and that changing its inputs and
output protein will not affect its behaviour. The TESs we characterised here use the same input
promoters (Ptet and Ptac) and tuner (THS-20) to regulate the same protein (YFP). For the TES
to be used in a larger circuit it will need to be used to regulate different proteins and will likely
need different inputs. Removing the RiboJ insulator improved the TES’s performance, but at the
same time we lost the functionality of the insulator. If this optimized device were to be used with
different input promoters it would alter the 5’ untranslated region and likely alter the rate of
translation of our gene of interest [83]. Furthermore, the THS we used contains a linker that
adds 11 residues to the N-terminus of the regulated protein [55]. Whilst this does not appear to
affect YFP function, it could hinder the function of proteins that are sensitive to changes in their
N-termini.
To make it easier to connect devices in order to build larger circuits, device inputs and outputs
are often standardized so that they use the same signal. For example, biodesign automation
software like Cello uses transcriptional logic gates as modules. Each module’s input and output
uses RNAP flux at a promoter as a standard signal carrier [19, 100]. In the next chapter, we use
the TES to build a tuneable NOT gate with standardized inputs and outputs. In the NOT gate,
the TES regulates the production of a key protein in the gate (a repressor protein), allowing us to
control a key feature of its function – the transition point between its on and off output states.
NOT gates can be combined with other transcriptional logic gates to build larger circuits capable
of performing a wider range of functions, so tuneable NOT gates are a first step towards building
circuits that can be tuned and fixed using our TES.
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6.1 Introduction
Some genetic devices rely on the expression of proteins such as transcription factors to implement
basic logic functions. Many of these can be composed to carry out more complex decision-making
tasks [100, 124]. One such commonly used device is a NOT gate, which has a single input
and output [124]. Its function is to ‘invert’ the input such that the output is high if the input
is low and low if the input is high. Such a behavior can be implemented using promoters as
inputs and outputs, with the input promoter driving expression of a repressor protein that binds
to a constitutive output promoter. When the input promoter is inactive, the repressor is not
synthesized, so the output promoter is active. When the input promoter is active, the repressor
protein is produced. This binds to the output promoter, blocking RNA polymerases (RNAP) from
transcribing downstream genes, causing the output promoter activity to decrease when the input
promoter activity increases.
When connecting gates to build a larger circuit, the output promoter of one gate acts as the
input to the next. The relationship between a NOT gate’s input and output is represented as
a sigmoidal response function, where increases in input promoter activity decrease the output
promoter activity. Connected logic gates propagate a Boolean signal, which can be either ‘on’
or ‘off ’, through a circuit. For a signal to pass between gates, gates’ response functions need to
exhibit switching-behaviour; whereby, low and high input promoter activities, corresponding to
‘off ’ and ‘on’ input states, when mapped onto a response function, illicit two distinctive output
signals that are either above or below a threshold.
A problem faced when connecting two gates is that, if the transition point between on and
off states of the first is too low, the output promoter activity may not span the transition point
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(K-value), which leads to an output that is permanently on or off. In this case, the gates are
said to be mismatched and so the input signal can’t propagate through the circuit. One or more
mismatched pairs of gates in a circuit can impact its function, causing it to break. Thus, for gates
to be matched, the transition point of both gates needs to be at a ‘sweet spot’, such that signals
can propagate robustly.
To get around the problem of mismatched gates, biodesign automation (BDA) software such
as Cello matches response functions to make sure that the transition points of connected gates
are compatible with each other [100]. Mismatched gates can be fixed by modifying regulatory
elements in their design. In the case of repressor-based NOT gates, while the promoters cannot be
easily modified, in bacteria the translation initiation rate can be varied by altering the ribosome
binding site (RBS) for the repressor gene. Increasing the RBS strength causes more repressor
protein to be produced for the same input promoter activity (number of transcripts), shifting
the transition point to a lower value [100]. While such modifications can fix issues with device
compatibility, they require reassembly of the entire genetic device. In this chapter we propose
a different solution to the problem and use a tuneable expression system (TES) to vary the
translation rate of a gene with a NOT gate, allowing us to vary its transition point from an on to
off output states.
The way a genetic part, device or circuit behaves is dependent on the environment it is used
in. Cello accounts for this by allowing a user to define a user constraint file (UCF), where the
conditions that parts or devices were characterised in are stated. However, most genetic parts and
devices are tested under standard lab conditions, at 37 ◦C in a standard, predefined media [100].
This is fine for designing a proof of concept circuit, however, for circuits to be able to work in real
world applications, such as in industrial scale bioreactors, they need to be robust to changes in
environmental conditions. Changing the environment cells are grown in changes the response
functions of circuits they harbour. Whilst a circuit might work under standard lab conditions, it
is likely to break when grown in the varied conditions cells are exposed to in industry.
For example, when cells are grown at industrial scales, they are subjected to a range of
different glucose concentrations as they circulate around bioreactors. These differences in glucose
can have significant effects on the behaviour of the microorganisms. If glucose concentration is
too high, cells grow too fast and use up all of the available oxygen in the local environment, which
in turn triggers a stress response that significantly affects their physiology and how they express
genes [42]. Similarly, if there is insufficient glucose, cell growth rates will drop, affecting the rate
of protein production in cells and therefore the overall process [74, 75]. These effects will likely
change the way synthetic circuits behave.
This chapter is structured as follows. In Section 6.2 we present a model to predict the
behaviour of a tuneable NOT gate. We use this model to inform the physical construction of a
tuneable NOT gate. Then, in Section 6.3 we build and test four variants of our tuneable NOT
gate design, corresponding to the four variants of the TES we tested in Chapter 5. In Section
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6.4 we show that the concentration of glucose that cells harbouring the TES are grown in affects
the rate that they produce proteins. Finally, we demonstrate that, for a fixed input, we can tune
the rate of protein production in different glucose concentrations, to ensure the rate of protein
production is constant across all concentrations of glucose.
6.2 Model guided design of a tuneable NOT Gate
We created a proof-of-concept tuneable NOT gate that integrates a TES to allow its response
function, and crucially its transition point, to be altered after assembly. We chose an existing NOT
gate design that uses the PhlF repressor to control the activity of the output PphlF promoter [124].
Expression of PhlF was controlled by the TES (replacing the YFP reporter protein in the original
TES design). Unlike the TES, the tuneable NOT gate uses promoters for both inputs and outputs
allowing it to be easily connected to other devices that use RNAP flux as an input/output signal.
By using a common signal carrier the tuneable gate can be incorporated into BDA software such
as Cello [100].
The NOT gate uses the TES to tune the production of a repressor protein, so we used the
output from the TES model to demonstrate how the concentration of repressor, P, changes with
input and output promoter activities. Once translated, the repressor binds to a constitutive
output promoter (Figure 6.1). As we increase the concentration of repressor, the activity of the
output promoter, rO, decreases. We captured this relationship using the Hill function:
rO =αmin + (αmax −αmax)
Kn
Kn +Pn , (6.1)
where , αmin and αmax are the minimum (basal) and maximum promoter activities, respec-
tively, K is the repressor concentration at which the output promoter activity is halfway between
its minimum and maximum, n is the Hill coefficient (cooperativity), and P is the steady state




= rM −k+C MS+k−CC−γM M (6.2)
dS
dt
= rS −k+C MS+k−CC−γSS (6.3)
dC
dt




rO =αmin + (αmax −αmax)
Kn
Kn +Pn (6.6)
where M, S, C and P are the concentrations of mRNA, sRNA, complex (formed from mRNA
and sRNA binding) and protein, respectively. M and S are transcribed at rates of rM and rS,
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Table 6.1: Parameters used to model a tuneable NOT gate.
Name Description Value(s) Unit Ref.
αmin Minimum (basal) output promoter ac-
tivity
0.0015 RNAP min-1 [72]
αmax Maximum (basal) output promoter ac-
tivity
500 RNAP min-1 [72]
K Repressor concentration where output
promoter activity of the NOT gate is
halfway between its minimum and
maximum
4.76 proteins cell−1 [85]
n Hill coefficient for PhlF repressor 4 - [85]
respectively. k+C and k
−
C are the reaction rate constants for complex formation and dissociation,
respectively. βC is the reaction rate constant for translation of mRNA. M, S, C and P are degraded
at a rate proportional to their concentration and rate constants, γM , γS, γC and γP , respectively.
P is solving Eqs. (6.2 - 6.5) at steady state.
To model the NOT gate, the outputs from the simulations we ran for the TES (Chapter 4),
were used to calculate the expected repressor concentrations to be used in Eq. (6.6). We wanted
to better understand how a NOT gate built with the repressor protein PhlF would behave so we
chose biologically realistic parameters from the literature to assess how PhlF would repress the
activity of it’s related output promoter (Table 6.1).
Using this model, we simulated how steady state concentration of repressors and output
promoter activity change as we varied input and tuner promoter activities, and association
constants for the hybridization of sRNA and mRNA. We found that, as we increased input
promoter activity there was a non-linear decrease in output promoter activity. We saw this at all



















Tuneable NOT gate 
rs
Figure 6.1: Key processes in a tuneable NOT gate. Parameters rm, rs and r0(P) are the input
promoter activity, tuner promoter activity and output promoter activities, respectively. k+C , k
−
C and βP are
the rate constants for association of mRNA and sRNA, dissociation of mRNA and sRNA and translation
of repressor protein, respectively. γ denotes a degradation constant, where the subscript represents the
biochemical species being degraded. m, s, C and P are the mRNA, sRNA, complex formed between sRNA
and mRNA and repressor protein, respectively.
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There was a non-linear decrease in the fold-change between output promoter activities at low
and high input promoter activities as we increased the tuner promoter activity. As tuner promoter
activity was increased from 0.0001 to 730 RNAP min−1, fold-change decreased: 10,000, 50 and
2–fold, at rate constants of sRNA and mRNA association of 0.0257, 0.257 and 2.57 complexes
transcript−1 min−1, respectively (Figure 6.2C).
Increasing the rate of association reduced the range of output promoter activities over which
we can tune the NOT gate. At low input promoter activities (0.0001 RNAP min−1), increasing
tuner promoter activity from 0.0001 to 730 RNAP min−1 caused the output promoter activity
to decrease 6800, 20 and 1.7-fold at mRNA-sRNA association rates of 0.0257, 0.257 and 2.57
complexes transcript−1 min−1, respectively. As the rate of association between sRNA and mRNA
increases, mRNA binds sRNAs at a faster rate, so for any input or tuner promoter activity, there
are more mRNA molecules bound by sRNA that can be translated, leading to higher repressor
concentrations.
6.3 In-vivo performance of a tuneable NOT gate
Based on these findings we built a tuneable NOT gate that uses a TES to regulate the production
of PhlF (Figure 6.3). We constructed two variants. The first had a RiboJ insulator upstream
of the THS; we refer to this variant as the insulated NOT gate. The second is a non-insulated
variant, where the RiboJ insulator upstream of the THS has been removed. To measure the
activity of the output promoter PphlF , we placed a YFP reporter cassette downstream of the
promoter (Figure 6.3). The cassette uses a RiboJ insulator upstream of the YFP to insulate
translation of the YFP, so its rate is less affected by the 5’-untranslated region upstream of the
YFP transcript.
Using the YFP cassette allowed us to convert NOT gate output fluorescence into relative
promoter units (RPU) by comparing output fluorescence to the fluorescence of a standard plasmid
(pAN1717) which uses a constitutive promoter to drive expression of the same YFP cassette [100].
Expressing promoter activities in RPUs, allowed us to compare them to other measurements
found in the literature (Chapter 3, Materials and Methods) [19, 100].
We tested the proposed design in-vivo by transforming E. coli cells with the insulated (pVB002)
and non-insulated variants (pVB004) of the tuneable NOT gate and performed additional co-
transformations for each variant with the sRNA booster plasmid (Chapter 5). As with the TES,
cells harboring the devices were grown in varying concentrations of aTc and IPTG, to modify the
activity of the input and tuner promoters, respectively. The activity of the output promoter was
inferred by measuring the fluorescence of single cells using flow cytometry, then converting this
data into RPU units (Chapter 3, Section 3.4.5)
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Figure 6.2: Deterministic modelling of a tuneable NOT gate. The rate of transcription of mRNA
(Input) was increased from 0.0001 to 300 RNAP min−1. The rate of sRNA transcription (Tuner) was
increased in intervals between between 0.0001, 0.0005, 0.0024, 0.012, 0.056, 0.27, 1.3, 6.4, 31, 150 an
730 RNAP −1, with changes in interval denoted by changes in band color from light to dark. The rate
of association between sRNA and mRNA were modelled at, from left to right, 0.0257, 0.257 and 2.57
complexes transcript−1 min−1 (A) Change in output promoter activity with input. (B) Concentration of
repressor proteins (repressors) against input. (C) Fold change between NOT gate output promoter activity
when input promoter activity is 0.0001 and 300 RNAP −1, plotted against tuner activity.
6.3.1 Modifying repressor production tunes NOT gate transition
We plotted the relationship between output promoter activity and input promoter activity for
varying levels of tuner activity (Figure 6.4A). Similar to our modelling results, the experimental
response functions showed a negative sigmoidal shape. We fitted the data to a Hill function to
find the transition points, K-value, of each response function. For the insulated gate without the
sRNA booster plasmid, we found that there was a 7-fold difference in transition points between
devices used at the highest and lowest tuner promoter activities (Figure 6.5). Increasing tuner
promoter activity led to transitions at a lower input. The range of transition points achieved by
our insulated gate covered a high proportion (35%) of the largest collection of repressor-based
NOT gates built to date (total of 20 variants) (Figure 6.5) [100].
These results demonstrate that the TES could be used to construct a NOT gate where
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Figure 6.3: Tuneable genetic NOT gate implementation. Schematic of the tuneable NOT gate (top)
and genetic design of the gate (bottom). The output promoter PphlF drives production of a yellow fluorescent
protein (YFP). T1 and T3 are transcriptional terminators L3S3P11 and ECK120033737, respectively.
transition point can be varied to improve compatibility with other genetic devices. However,
tuning the gate came at a cost. As we predicted from our model (Figures 6.2C), increasing the
tuner promoter activity decreased the fold-change between output promoter activities associated
with low and high input promoter activities (Figures 6.4A and B). In our experimental system,
increasing tuner promoter activity from 0.002 RPU to 0.9 RPU resulted in a 78% decrease in
fold-change. As we increased tuner promoter activity there was a sigmoidal increase in the
intersection of overlap between output YFP fluorescence distributions for cells grown at high
(1.51 RPU) and low (0.0001 RPU) input promoter activities (Figures 6.4A and C). This increase
was 4.5-fold as tuner promoter activity increased from 0.002 RPU to 0.9 RPU.
Once the tuner promoter activity reached a maximum working limit, increasing it any further
made the fold-change too low and intersection between on and off states too high for the gate to
be useful. Once this limit was exceeded, it became impossible to tell if in cells in a population are
on or off.
6.3.2 Insulator and sRNA booster plasmid affect gate performance
We attempted to improve the performance of the tuneable NOT gate by characterising the
insulated gate variant in cells co-transformed with the booster. The sRNA booster considerably
improved the performance of the TES, so we thought it might improve the performance of the
NOT gate too. However, compared with the original gate, the fold-change decreased at all tuner
promoter activities we tested (Figure 6.4B). At low (0.002 RPU) and high (2.61 RPU) tuner
promoter activities, fold-change decreased by 3% and 38%, respectively (Table 6.2). The range
of transition points also decreased from 7-fold to 5-fold (Figure 6.5). The inclusion of the sRNA
booster likely increased overall PhlF concentrations as the transition points shifted to far below
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Figure 6.4: Characterisation of tuneable NOT gates. Points are averages of three biological replicates
and error bars show ±1 standard deviation. (A) Steady state response functions of tuneable NOT gate
variants. Lines are fitted hill functions at a single tuner promoter activity (light–dark: 0.002, 0.03,
0.15, 0.43, 0.90, 2.61 RPU). (B) Change in fold change between output promoter activities when input
promoter activity is low (0.0001 RPU) and high (1.5 RPU), with tuner promoter activity. (C) Change in the
intersection between output fluorescence population distributions with tuner promoter activity at low and
high input promoter activities.
what had been seen for the original design. This would make this specific design of value for uses
where a weak input signal needs to be inverted and amplified simultaneously.
We further improved the performance of the TES by removing the RiboJ insulator upstream
of the THS part, which interfered with THS performance by preventing it from folding correctly
and occluding ribosomes. The misfolded THS was also unable to be fully activated by sRNA.
Removing the insulator decreased the rate of protein production at low input promoter activities
and increased the rate of protein production at high input promoter activities, which worsened
the TES’s performance.
Based on how removing the RiboJ insulator improved TES performance, we thought the
non-insulated NOT gate would perform better than the insulated variant. We expected the
non-insulated TES embedded in the NOT gate to produce less PhlF at low inputs and more PhlF
at high inputs, resulting in a higher output promoter activity at low inputs and lower output
promoter activities at high inputs. This would in turn increase the device’s fold-change compared
to the insulated NOT gate.
We tested the non-insulated variant of the tuneable NOT gate, both without and with the
booster. Compared to the insulated variant, the fold-change of the non-insulated variant was 13%
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higher at a low tuner promoter activity (0.002 RPU) and 17% higher at a high tuner promoter
activity (2.61 RPU) (Table 6.2, Figure 6.4B). The intersection at low and high tuner promoter
activities decreased by 42% and 15%, respectively (Table 6.2, Figure 6.4C). The fold-change
and intersection for the non-insulated design increased and decreased, respectively, because the
output promoter activity at high input promoter activity was lower than in the insulated device.
When comparing the non-insulated design to the insulated design at high input promoter activity
(when we expect low outputs), the output promoter activity was 9.5% and 11% lower at low and
high tuner promoter activities, respectively.
The output promoter activity from the non-insulated variant with the booster was 60%
higher at low input and tuner promoter activities than from the insulated variant (Figure 6.4A).
Compared to the insulated variant with the booster, the non-insulated TES with the booster
produced 20% more protein at low input and tuner promoter activities (Figure 5.5). Despite the
increase in output promoter activity at low input and tuner promoter activities, the fold-change
of the non-insulated NOT gate decreases when it is expressed with the booster. At low and high
tuner promoter activities, fold-change is 10% and 24% lower, respectively. These decreases likely
occur because at high input promoter activity, when output promoter activity should be low, the
output promoter activity is higher in the non-insulated gate with the booster for almost all tuner
promoter activities we tested (Figure 6.4).
We chose to use the PhlF repressor in our NOT gate because in previous works, PhlF based
NOT gates have been shown to perform well, exhibiting large dynamic ranges and fold-changes
[100, 124]. For example, Nielsen et al., built three variants of a PhlF NOT gate with each using

















Figure 6.5: Comparison of NOT gate transition points. The range of transition points (K-values) of
the insulated gate (v1), insulated gate with booster (v1+), non-insulated gate (v2) and non-insulated gate
with booster (v2+) are compared with transition points of repressor based NOT gates used in Cello [100].
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Table 6.2: Performance summary of the NOT gate designs
Dynamic rangea,b(a.u.) Fold-changea,c(a.u.) Intersectiona,d
Design Lowe High f Lowe High f Lowe High f K range
Original 8.15 ± 0.6 1.66 ± 0.134 6.0 ± 0.147 1.45 ± 0.09 0.19 ± 0.046 0.84 ± 0.02 0.009–0.067
sRNA boosterh 10.4 ± 0.75 1.02 ± 0.31 5.8 ± 0.31 0.9 ± 0.25 0.13 ± 0.07 0.85 ± 0.02 0.012–0.063
Non-insulatedi 8.24 ± 0.91 1.76 ± 0.39 6.8 ± 0.28 1.7 ± 0.23 0.11 ± 0.03 0.71 ± 0.08 0.021–0.046
Combined j 13.09 ± 1.46 1.12 ± 0.08 6.09 ± 0.56 0.91 ± 0.06 0.08 ± 0.05 0.9 ± 0.03 0.003–0.022
a. Average values are shown ± 1 standard deviation calculated from flow cytometry data for three biological replicates.
b. Dynamic range calculated as the absolute difference in YFP fluorescence between low (0.002 RPU) and high (1.5
RPU) inputs).
c. Fold-change in YFP fluorescence (corrected for cell autofluorescence) for low (0.002 RPU) and high (1.5 RPU) inputs.
d. Fraction of intersection between the flow cytometry YFP fluorescence distributions for low (0.002 RPU) and high
(1.5 RPU) inputs (3).
e. Performance measured for a low tuner input (0.002 RPU).
f. Performance measured for a high tuner input (2.61 RPU).
g. Range of K values from Hill functions fitted to experimental data.
h. Original designs (Figure 5.8) with the sRNA booster system (Figure 5.4).
i. Design without RiboJ insulator.
j. Design without RiboJ insulator but with sRNA booster (Figure 5.4).
a different RBS [100]. For the three variants, the maximum activity of the output promoter
PphlF was between 3.9 and 6.8 RPU and minimum activity was between 0.01 and 0.02 RPU. The
fold-changes of the devices ranged between 205 and 390, two orders of magnitude higher than we
see from the tuneable NOT gates. The maximum output promoter activities from our tuneable
NOT gate ranged from 8 to 13 RPU, values higher than those seen in Nielsen et al.’s gates. The
output promoter activity at high inputs, for all our tuneable NOT gate designs was always at
least 37-times higher than for their gates, suggesting that the tuneable NOT gates do not repress
the PphlF promoter activity as well.
6.4 Effect of glucose concentration on device performance
Even if a circuit is well designed to combine gates that match and then tested and verified in the
lab, changing the environment a circuit is used in could change the shape of the circuit’s response
function, causing devices to mismatch and circuits to break. Despite this, we still characterise
genetic parts in stable environmental conditions. For genetic circuits to be used in the real world,
they need to be able to adapt to a range of environmental conditions. The first step towards
building circuits that are robust to changes in environmental conditions is to build tuneable parts
and devices that can adapt or be tuned depending on the environment they’re in. To validate
this approach, we need to start testing circuits in a range of different conditions that represent
their end-use environments. In this way, we can discover how well circuits perform in different
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environments. We can use this new understanding to build better genetic parts, devices and
circuits.
The environment that cells are grown in directly affects their physiology and how they express
genes. In this section, we investigated how an important variable in industrial bioreactors, glucose
concentration, affects the performance of the TES. We did this to show how glucose concentration
that cells are grown in affects the performance of our device and to demonstrate that the rate
of gene expression from the TES can be tuned so that its behaviour remains constant across
conditions. Because rates of protein production and device performance are directly related to
growth rates, we initially investigated the effect of glucose concentration on the growth rate of
cells harbouring the TES.
6.4.1 Cells grow faster in high glucose concentrations
To find out how glucose concentration affects the growth of cells, we measured the optical density
of cells harboring the best performing TES design, the non-insulated variant, over time as
they grew in glucose concentrations that varied over a 1000-fold range. We fitted the growth
curves to a mathematical model and calculated the maximum growth rate of cells grown at each
concentration of glucose by numerically calculating the maximum gradient of the fitted curves
(Chapter 3, Section 3.4.8) (Figure 6.6B) [35] .




































Figure 6.6: Effect of glucose concentration on cell growth. (A) Growth curves for cells grown over
350 minutes. Glucose concentration that cells were grown in is marked above each plot. Coloured circles
are technical replicates. Coloured lines show a fitted mathematical model [35]. (B) Maximum growth rate,
is plotted against glucose concentration.
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concentration of glucose they were characterised in was increased between 0.04–4 g L−1. However,
increasing glucose concentration above 4 g L−1 had little effect on growth rate. Increasing glucose
concentration to 16 and 40 g L−1 only resulted in growth rates 2.45 and 2.36–fold higher than at
0.04 g L−1. These differences in growth rates show that, when glucose concentration is between
0.04 and 4 g L−1, cells grow faster at higher concentrations of glucose (Figure 6.6B). Above
4 g L−1, the effect of increasing glucose concentration on growth rate appears to plateau, and
increasing glucose concentration has little effect. This indicates that glucose is a growth limiting
substrate until glucose concentration is greater than 4 g L−1.
6.4.2 Glucose concentration affects the performance of the tuneable
expression system
We ran further experiments to see if cells produced protein at different rates depending on the
concentration of glucose they were grown in. To do this, cells containing a TES (the non-insulated
variant) were grown in different concentrations of aTc and IPTG, to vary the input and tuner
promoter activities, respectively. Three different concentrations of glucose (0.04, 0.4 and 4 g L−1),
were used. Cells were sampled at 4 time points over a 3 hour period to see how the rate of YFP





where β is the rate of protein production, γ is the rate of protein loss and P is the concentration
of protein. At steady state the equation becomes:
β= γP . (6.8)
We can calculate the rate of protein production by multiplying the concentration of protein
by the rate of protein degradation and dilution. Because proteins are stable at the time scales
considered, protein is mainly lost through dilution due to cell division [99]. When cells divide, all
the proteins in a single cells are split, halving the number of proteins in each cell. We calculated
the relative rate of protein production between samples by multiplying YFP fluorescence by
growth rate. At all input and tuner promoter activities and time points we tested, the rate of
protein production was lowest for cells grown in media containing the lowest glucose concen-
tration, 0.04 g L−1 (Figure 6.7). We looked at protein production when cells were growing in
exponential phase (at 120 minutes), as at this point, the rate of change in protein production is
at steady state. We see that compared to cells grown in media with 0.04 g L−1 of glucose, the rate
of protein production increased by between 25–174% and 12–140% for cells grown in 0.4 and 4
L−1 of glucose, respectively (Figure 6.7B).
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Figure 6.7: Effect of glucose concentration on protein production. (A) Change in protein produc-
tion rate in cells grown in glucose concentrations of 0.04 (light-green), 0.4 (dark-green) and 4 g L−1 (blue),
over 180 minutes. (B) Percentage difference in protein production rate compared to cells grown in 0.04 g
L−1 of glucose. Circles are averages of three biological replicates, error bars show ± 1 standard deviation.
Growing cells in different concentrations of glucose has no apparent effect on the steady
state response function of the TES (Figure 6.8). However, there are several difference in the
performance. At low tuner promoter activities (0.002 RPU), the TES characterised in glucose
concentrations of 0.4 and 4 g L−1 had fold changes between the rates of protein production at low
and high inputs 40 and 36 times higher compared to when they were characterised in 0.04 g L−1
(Figure 6.8B). At high tuner promoter activities (2.61 RPU), the fold change was only 1.43 and
1.05 times higher when characterised in 0.4 and 4 4 g L−1, compared to at 0.04 g L−1 (Figure
6.8B). Thus, the concentration of glucose clearly affects the performance of the TES, with the
biggest effect seen at low tuner promoter activities, when the TES produces sRNA at a lower rate.
If a large circuit was used in conditions where glucose concentration varied, the device’s
performance could vary. A potential solution to this problem is to use a TES. The TES allows us
to tune the rate of protein production, so that the device produces protein at the same rate in any
glucose concentration. For example, at an input promoter activity of 6.06 RPUs, the TES can be
used to tune the rate of protein production to be 0.009 a.u. min−1, irrespective of how changing
concentrations of glucose effect protein production. To do this we would adjust the tuner promoter
activity by varying the relevant inducer to dynamically alter the rate of protein production to be
100%, 10% or 14% of the maximum rate that protein is produced at in cells grown in 0.04, 0.4
and 4 g L−1 of glucose, respectively (Figure 6.8C).
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Figure 6.8: Effect of glucose concentration on device performance. Performance of TES grown in
varying concentrations of glucose 120 minutes after induction. Circles are averages of three biological
replicates, error bars are ± 1 standard deviation.(A) Steady state response function of tuneable expression
system (TES) grown in varying glucose concentrations that are shown above each plot. Grey markers
and coloured markers show protein production at low (0.002 RPU) and high (2.61 RPU) tuner promoter
activities, respectively. (B) Change in fold-change in rate of protein production for TESs grown at high
(6.06 RPU) and low (0.002 RPU) input promoter activities with glucose concentration. Light and dark
purple denote low (0.002 RPU) and high (2.61 RPU) tuner promoter activities, respectively. (C) Range of
protein production rates over which the TES can be tuned at different concentrations of glucose (left), the
percentage of the maximum rate of protein production that the TES needs to be tuned to produce protein
at a rate of 0.009 a.u. min−1, in different concentrations of glucose (right).
6.5 Discussion
In this chapter, we built and tested four variants of a tuneable NOT gate: an insulated design,
where the RiboJ insulator was placed upstream of the THS that regulates translation; a non-
insulated design, where the RiboJ upstream of the THS had been removed and both of the first
two variants were also co-transformed and tested with a sRNA booster plasmid. We showed that
it is possible to tune the transition points of the tuneable NOT gates (Figure 6.5). The transition
point for the insulated device without the booster could be tuned over the largest range, with
the highest transition point being 7-fold higher than the lowest, a range of transition points that
spans 35% of the largest library (made up of 20 variants) of repressor based NOT gates built
to date [100]. To decrease the transition point, we had to increase the tuner promoter activity.
However, for all four variants, as we increased the tuner promoter activity the fold-change of
the gate decreased significantly. Comparing the output promoter activity of our NOT gate to
data found in the literature, we found that the fold-change is low because the output promoter
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activity is too high at high input promoter activities. This could be caused by RNAPs recruited to
transcribe PhlF continuing past the terminator and transcribing the downstream YFP. However,
because PhlF binds to PphlF downstream of the terminator, the repressors might physically block
RNAPs that have read through an upstream terminator, preventing transcriptional read-through.
PhlF represses transcription by binding upstream of a transcriptional start site which pre-
vents RNAP from binding to DNA and initiating transcription [124]. Whilst the repressor prevents
RNAP forming a complex with the DNA, it is not clear whether the repressor will inhibit an
RNAP which has initiated transcription upstream, from elongating a transcript. However, reports
in the literature suggest that repressors do not halt transcription of genes after transcription has
already been initiated [106, 119].
We only see a low output promoter activity when the rate of PhlF production is at its highest
(when input and tuner promoter activities are highest), so the terminator that halts transcription
of PhlF prevents transcriptional read-through to an extent, but not completely. The basic PhlF
gates tested in the literature [100], use the exact same terminator (ECK120033737) as we used
to terminate transcription of the PhlF, but they do not see signs of transcriptional read-through.
Transcription of PhlF in the basic PhlF gate was regulated by Ptac but in our tuneable gate it was
regulated by Ptet, which has a maximum promoter activity 37% higher than Ptac[100]. Therefore,
in our system, when the input promoter activity is at its highest, 37% more RNAPs are recruited
to transcribe PhlF, so more RNAPs would read through the terminator than in the basic gate.
This could account for the difference in output promoter activity at high input promoter activity.
These results highlight the importance of using more insightful and quantitative methods of
capturing how well parts work, such as RNA sequencing [50]. In the case of our tuneable NOT
gate, transcriptional read-through appears to reduce the devices performance by limiting the
fold-change in output promoter activities when input promoter activities are low and high.
Even if the performance of genetic devices is improved by building them in a way that
prevents transcriptional read-through, the environment that cells are harbouring a device are
grown in can impact performance. If circuits are not being tested in environments relevant to the
conditions they’re built to be used in, we cannot predict how they will behave in industry, making
it difficult to design and build circuits for this purpose.
To emulate environmental conditions that a device would be exposed to in industry, we grew
cells in 0.04 , 0.4 and 4 g L−1 of glucose and measured their fluorescence at 4 time points over
180 minutes, as cells were grown in varying input and tuner promoter activities. The fold-change
in the device’s protein production rate when it was grown with high and low input promoter
activities, was 10% and 25% lower at low and high tuner promoter activities, respectively, when
cells grown were grown in 4 g L−1 glucose compared to cells grown in 0.04 g L−1 glucose. This is
likely because growing cells in low glucose concentrations stresses them, causing them to express
a number of genes that alter their physiology in a way that further reduces the rate they produce
protein [75, 75, 121].
95
CHAPTER 6. APPLICATIONS OF A TUNEABLE EXPRESSION SYSTEM
We would expect cells grown in the highest concentration of glucose (4 g L−1), to produce
protein at a greater rate than cells grown in 0.4 g L−1, but they don’t. If cells are grown in more
glucose than they need to survive, they grow too fast, using up oxygen available to them. Cells
starved of oxygen use different native metabolic pathways which changes the availability of
cellular resources and, therefore, the rate of protein production [42]. This could explain why,
despite the growth rate of cells increasing at 4 g L−1 compared to 0.4 g L−1, the rate of production
does not increase. To validate this hypothesis, we could grow cells in media containing varying
glucose concentrations and measure the dissolved oxygen concentration in the media.
Finally, we show that for a fixed input promoter activity of 6.06 RPU, the TES can be tuned
so that the rate of protein production is always the same, regardless of changes in glucose
concentration. This result is significant as it shows that the TES could be tuned to maintain
constant performance as changes in the environment change rates of gene expression. Previous
efforts have been made to build circuits that dynamically adapt to their environment, by using
sensors that detect the concentration of some external chemical [96] or by activating circuits
in response to an internal cellular process, such as metabolic burden [27]. Our devices could
be combined with such approaches, so that the performance of a device or circuit could be
dynamically tuned in response to changes in external chemical concentration or metabolic burden.
Furthermore, our tuneable devices offer synthetic biologists another tool they can incorporate
into circuits, which could reduce the time taken to engineer a working product.
Previously when circuits broke due to imbalanced gene expression, or mismatched device
response functions, they would have to be redesigned and rebuilt. Our tuneable devices provide
an alternative approach. They can be incorporated into larger circuits and if the circuit breaks,





The motivation behind this theses was to to develop tools and methodologies that would help
reduce the number of DBTL cycles needed to engineer working genetic systems. We aimed to
build genetic devices whose behaviours can be dynamically modified after their assembly, cutting
the cost and time needed to engineer genetic circuits. If a circuit built from our devices does not
work as expected, we can simply tune the devices to fix the system.
To tackle this problem, we developed a tuneable expression system (TES), where the rate of
transcription and translation of a gene of interest can be dynamically controlled. We optimized
the device’s performance by improving its fold change and usability in populations of cells and
show that it can be used to build a tuneable genetic NOT gate. Following on from this we showed
that changing the glucose concentration that cells are grown in alters the rate that they produce
protein. Finally, we demonstrated that the TES can tune protein production rates so that they
remain constant in different concentrations of glucose.
In Chapter 4, we designed, built and tested a prototype TES. We modeled the TES’s behaviour
and showed how the relationship between the input and output can be modified. To realize the
device in-vivo, genetic sensors Ptet and Ptac were used to regulate its input and tuner. We used
the TES to vary the rate of protein production over a range of inputs and found that we could
alter the shape of its response function. To investigate the dynamics of protein production by the
TES, we characterised protein production rate over time when the device’s inputs were varied.
Whilst our initial design demonstrated that the concept of a TES is feasible, the device didn’t
perform well. For a signal to propagate between connected devices, the range of outputs from
the first device must be large enough to span the inputs to the second [13, 130]. We expected the
range of outputs from the TES to be similar to those of the input sensor, but they’re significantly
smaller. The limited range of outputs from the device make it incompatible for use in large
circuits, where devices’ outputs need to have large dynamic ranges for a signal to propagate
robustly [100]. Furthermore, individual cells in populations grown at low and high input promoter
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activities showed similar output fluorescences, so for a large percentage of cells in any population,
it is impossible to determine whether the device’s output is low or high. For large genetic circuits
to function as intended, they need to be built from devices that produce two distinct signals when
their inputs are in low and high states [6, 100].
To address this limitation, in Chapter 5, we aimed to optimize the TES design. We used
deterministic and stochastic models to show that increasing the rate that sRNA is transcribed in-
creases the device’s fold change and decreases the intersection between fluorescence distributions
for the TES. We built a second "sRNA booster" plasmid that lead to overall higher transcription
rates for the sRNA than the original device when co-transformed with the TES. We characterised
the effect of the sRNA booster plasmid and confirmed what our model had predicted. In our initial
design we used an insulator part that might have interfered with how the THS RNA folds and
functions, hindering the TESs performance. A thermodynamic model showed that the insulator
physically binds to the THS and decreases the rate that the THS folds, preventing repression
of translation and sRNA binding to the THS to activate translation. To test this in-vivo, we
constructed a non-insulated TES where the insulator part was removed. As predicted, removing
the insulator caused an increase in the fold-change of device outputs at all tuner promoter
activities. We combined the non-insulated TES with the sRNA booster and found that increasing
the rate that sRNA is transcribed for a non-insulated TES further increased the fold-change
and decreased the intersection between populations of cells. The RiboJ insulator that we used
in the TES is routinely used to make genetic device behaviour more predictable [34, 83, 100].
We showed that the insulator can interfere with how RNA based parts function. If synthetic
biologists are using ribozyme based insulators directly upstream of an RNA part, our results
recommend the use of thermodynamic modelling to check for possible interference.
Despite all these improvements, the fold-change of the TES still decreased substantially as we
tuned it. A potential explanation is that when we increase the rate of transcription of sRNA to tune
our device, RNAP reads through the terminator and transcribes the downstream gene, producing
mRNA even when the input promoter is not active [18, 32]. We chose strong terminators in all our
TES designs [32]. However, our results suggest that the L3S3P11 terminator we use to terminate
transcription of the sRNA was ineffective. This could be down to the way the terminator was
characterised. For example, the fluorescent protein based method used to characterise terminators
is not robust to contextual effects, so it is possible that the terminators are not as effective when
used in our circuit.
To connect genetic devices, their inputs and outputs need to use the same signals [19, 100]. In
Chapter 6 we designed and built a tuneable NOT gate, whose input and output is RNAP flux at a
promoter, by replacing the YFP in the TES design with the repressor protein PhlF and adding a
new output promoter, PphlF . We built NOT gates for the four variants of the TES: the original
design, the original design with a booster, the non-insulated design and the non-insulated design
with the booster. We showed that we can tune the transition point of all the gates. NOT gates have
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been shown to be valuable devices for building large circuits that carry out complicated functions,
however, large circuits rarely function as intended [100, 124]. One common reason circuits break
is that the input signal cannot propagate through the circuit due to the transition points of
connected devices being mismatched [13, 100, 130]. Until now, tuning a device’s transition point,
required rebuilding the circuit. In contrast, the tuneable NOT gate could be integrated into such
circuits and used to tune and fix transition points of mismatched devices; a quicker and cheaper
way to tune and fix a circuit. Tuneable NOT gates that can have their transition points tuned over
a larger range embody the functionality of a larger range of different "static" NOT gates. They are
better suited to be used within larger circuits, as circuits built with such a device encompass a
larger design space within a fragment of DNA of similar length. To this end, the gate built using
the original TES design performed best as it could be tuned over the largest range of transition
points and so embodied the functionality of the largest range of NOT gates.
Genetic circuits can be used to engineer cells to produce chemicals in industrial bioreactors.
However, bioreactors expose cells to a large range of different environmental conditions (i.e.
fluctuations in glucose concentration [42]), which may affect how a genetic circuit performs
[52, 95]. To overcome this problem, we show that the TES could be used to adapt protein
production rates so that they are constant in a range of glucose concentrations. By characterising
the TES in different concentrations of glucose, we demonstrated that the TES performs worse at
low glucose concentrations, when cells grow slower. In these conditions proteins were produced
at a lower rate which impacted the device’s performance. These results are interesting for anyone
engineering genetic systems for use in industrial bioreactors, where cells experience different
concentrations of glucose depending on where in the reactor they are at different points in time.
For genetic circuits that need to produce precise concentrations of proteins to function, this would
cause them to break [2, 138]. We show that for genes regulated by the TES, the rate of protein
production can be dynamically tuned so that cells produce protein at a constant rate in different
concentrations of glucose.
TESs could be valuable for engineering adaptive systems that tune gene expression in
response to changes in their environment. However, uses of the TESs we present here are limited
as they rely on external inputs (small molecules aTc and IPTG) to regulate gene expression. For
example, if we wanted to regulate expression of a gene in an industrial context where cells are
grown in large volumes of media, it would be too expensive and impractical to rely on such inputs.
Therefore, for the TES to be of practical use new autonomous TESs need to be designed to use
inputs and tuner inputs that regulate gene expression in response to signals that are either found
in the environment they are to be used in, such as substrate concentration or pH [77], or signals
that occur within cells, such as responses to metabolic burden [27].
The findings might also be of use to chemical engineers looking to find optimal concentrations
of glucose to grow cells in for producing proteins. The method we use, growing cells in different
conditions in parallel, can be applied to test circuits in ranges of other conditions relevant to
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industry. This work provides a first step towards a pipeline that provides a lab-scale environment
for testing genetic circuits and scaling their use for industrial contexts.
More broadly, this work contributes to the field of synthetic biology in a number of ways. First,
we have generated two sets of devices. (i) TESs that allow the rate of protein production to be
tuned and (ii) tunebable NOT gates that can have their transition points between on and off states
tuned and that are compatible for integration into large circuits that carry out more complex
functions [100]. Secondly, we discovered an important design rule for those using Ribozyme-
based insulators: when using insulators adjacent to RNA devices, ensure that their secondary
structures don’t interfere with each others function. Finally, we showed that the performance of
our devices changes in different concentrations of glucose. We then demonstrated that we can
tune the devices to produce protein at a constant rate in varying glucose concentrations, which
will be of interest to parties looking to build genetic circuits that are robust to perturbations in
environmental conditions.
7.1 Future directions
7.1.1 Use in biodesign automation
The contents of this thesis are useful to other researchers, however, there are several limitations
in what we can infer from the results we generate. We state that the way we designed a tuneable
NOT gate in Chapter 6 would allow us to use the device in biodesign automation (BDA) software
such as Cello [101]. Despite this being theoretically possible, we never tested out how well the
device would work in the software or whether it can be used to tune and fix larger circuits. A
future direction for this work would be to integrate the NOT gate design into Cello and use the
software to design a large genetic circuit. The circuits performance can then be improved by
tuning NOT gates.
7.1.2 Automated characterisation of devices
To build on our initial characterisations we could automate the characterisation of our devices to
yield large amounts of data that’s more reproducible than if experiments were done by hand [20].
Furthermore, automated sampling of growing cell cultures could generate high resolution time
course data, with which we could more accurately fit model parameters, yielding models that
better describe our experimental system and allow us to more accurately predict device behaviour
in-silico. Furthermore, automation would enable us to characterise our tuneable devices in a




7.1.3 Testing devices in different environments
In Chapter 6 we showed that testing the TES in different concentrations of glucose affects
its performance. Environmental conditions change how genetic parts and devices that make
up a circuit perform, which can cause the circuit to break. For genetic circuits to be used in
real world applications, where they are exposed to a range of environmental conditions, their
performance must be robust to the conditions they experience. Our tuneable devices allow us
to address this problem. By tuning the rate of protein production for individual genes in a
circuit, we can dynamically tune protein production rates so they’re constant in any environment,
making circuits adaptable to changing conditions. The next step would be to characterise our
devices in a range of conditions that engineered cells would be exposed to in industry, such as:
dissolved oxygen concentrations, available nitrogen (i.e. amino acid) concentrations, pHs and
temperatures. From here, we could swap the tuner input for a genetic sensor that detects changes
in a condition of interest, allowing the device to automatically tune its response function in
response to environmental perturbations.
7.1.4 Dynamically fixing broken circuits
We showed that we can build a tuneable NOT gate and that we can tune the gate’s transition
point between on and off states. A natural next step would be to build dynamic circuits that tune
themselves in response to changes in host cell physiology or their environment, making their
function robust to changes in contexts that would otherwise break them. For example, if a cell
produces a toxic protein, we could regulate the transcription of the protein using a tuneable NOT
gate. The THS part of the device could be coupled to an internal cellular process that tunes the
gate when the cell is stressed, down regulating the production of the toxic protein. An alarmone
such as ppGpp could be used as an indicator that cells are stressed. Instead of using a THS, we
could use a ppGpp responsive riboswitch to regulate the production of the repressor protein [120].
7.2 Outlook
The work presented here is a first step towards a new, more effective approach to engineering
living systems. Using our tuneable devices or taking inspiration from them, synthetic biologists
can start to move away from the design-build-test-learn cycle, in favour of a more intelligent
approach, where they can side-step days or even months of painstaking DNA assembly using our
novel design-build-test-tune framework. If widely adopted, these innovations could accelerate the
rate that functioning genetic circuits are engineered and in doing so advance the rate that world
















































































































































































































































































































































































































































































































APPENDIX A. APPENDIX A
Table A.1: Sequences of genetic parts used
Part Name Type DNA Sequence (written 5’ to 3’)
Ptac Promoter [100] AACGATCGTTGGCTGTGTTGACAATTAATCATCGGCTCGTATAATGT
GTGGAATTGTGAGCGCTCACAATT
Ptet Promoter [100] TACTCCACCGTTGGCTTTTTTCCCTATCAGTGATAGAGATTGACATC
CCTATCAGTGATAGAGATAATGAGCAC
PphlF Promoter [100] TCTGATTCGTTACCAATTGACATGATACGAAACGTACCGTATCGTTA
AGGT
PT7 Promoter [55] TAATACGACTCACTATAGGG







































L3S3P11 Terminator [32] CCAATTATTGAACACCCTTCGGGGTGTTTTTTTGTTTCTGGTCTACC
L3S2P21 Terminator [32] CTCGGTACCAAATTCCAGAAAAGAGGCCTCCCGAAAGGGGGGCCTTT
TTTCGTTTTGGTCC
ECK120033737 Terminator [32] GGAAACACAGAAAAAAGCCCGCACCTGACAGTGCGGGCTTTTTTTTT
CGACCAAAGG
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